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1.1. General introduction 
1.1.1 Definition, classification and epidemiology of intellectual 
disability (ID) 
Intellectual disability (ID) is a lifelong disability with major impact on individuals’ 
lives and their families, and is a prevalent disorder worldwide.  It has been estimated 
that the lifetime cost for medical care of a child born with an ID in the United States is 
roughly as high as US$ 80.000 (Patel et al., 2010; PCPID, 2012). In Indonesia, the 
lifetime cost of people with ID is not known yet. However, in 2010 the amount of 
Rp. 3,627 billion (approximately USD 416 million) was allocated from a state budget for 
people with disability (Irwanto et al., 2010). Having estimated that ID is ~12% of the 
population of people with disability (Marjuki, 2010; Irwanto et al., 2010), the Indonesian 
yearly budget for taking care of people with ID is about USD 50 million.  
The high cost of ID is not only a burden for the society, but for the families as 
well (Doran et al., 2012). The burden could even get worse if ID is compounded with 
other disorders, as individuals with ID are at greater risk of developing secondary 
health problems (Maiano, 2011). Some reports highlighted the existence of co-
morbidity of ID and other conditions such as mental disorders and obesity (Einfeld et 
al., 2011; Maiano, 2011).   
The terminology to describe ID has changed from idiocy, feeble mindedness, 
oligophrenia, mental deficiency, mental subnormality to mental retardation (MR). Over 
the last decade, an intensive discussion took place on how to properly name, define 
and assess ID (Salvador-Carulla et al., 2011). Nowadays, the term ID widely replaces 
the previous terminologies for policy, administrative and legislative purposes (Schalock 
et al., 2007; Salvador-Carulla et al., 2011). In 2010, the United States president Barack 
Obama signed into law S.2781, known as “Rosa’s Law”, which changes references in 
Federal statutes. The former term “mental retardation” is since then referred to as 
“intellectual disability” (van Bokhoven, 2011). 
ID is a large and heterogeneous collection of syndromic and nonsyndromic 
disorders, highly diverse in terms of both cognitive and non-cognitive functions, 
multifaceted and defined in various ways, thus a comprehensive definition is difficult to 
give. The most widely used definition is provided by the Diagnostic and Statistical 
Manual of Mental Disorders IV Text Revision (DSM-IV-TR) which was formulated by 
American Psychiatric Association (APA) (American Psychiatric Association and Task 
Force on DSM-IV, 2000). Other definitions have been given by the American 
Association on Intellectual and Development Disabilities (AAIDD) and the World Health 
Organization’s International Classification of Diseases (ICD-10) (Luckasson et al., 
2002). In general, all definitions include a significant limitation in both intellectual 
Chapter 1 
14 
 
functioning (IQ<70) and concurrent limitations in conceptual, social and practical 
adaptive skills, and manifesting before the age of 18.  
ID is subdivided into several classes on the basis of intelligence quotient (IQ) 
score. The DSM-IV-TR and ICD-10 subdivided it into four different degrees: mild, 
moderate, severe and profound. Table 1.1 presents classification of ID based on DSM-
IV-TR and ICD-10. The AAIDD classification focuses on the intensity of support 
required by the individual highlighted into overall impact of ID in daily life. 
Consequently, this classification is subdivided into four groups: intermittent, limited, 
extensive and pervasive.  
Table.1.1 Levels of intellectual disability as classified in DSM-IV-TR and ICD-10   
 DSM-IV-TR *) ICD-10 
Level of ID Classification IQ Level Classification IQ Level 
Mild 317 50-55 to 70 F70 50-69 
Moderate 318.0 35-40 to 50-55 F71 35-49 
Severe 318.1 20-25 to 35-40 F72 20-34 
Profound 318.2 <20-25 F73 <20 
*) The DSM-IV-TR considers a measurement error of approximately five points, as it may occur in 
intelligence tests.  
Adapted from American Psychiatric Association and Task Force on DSM-IV, (2000); Luckasson et al., 
(2002) 
It has to be considered that the ID definitions given by APA, AAIDD or WHO 
are mainly to highlight the amount of support needed for individuals with ID in order to 
succeed in society, rather than to point out the degrees of impairment. Nevertheless, in 
terms of epidemiological studies, those definitions impose various problems. For 
instance, ID individuals who die in the prenatal period or during infancy are not 
calculated and not included in epidemiological studies. Another problem is the 
disagreement by what “general intellectual functioning’ exactly means and moreover 
there is no available validated test for it. In addition, no single measurement of adaptive 
behaviour that measures the ten skill domains is available (Leonard and Wen, 2002; 
Regan and Willatt, 2010). Therefore, a newly designed definition which is expected to 
overcome these problems is needed. 
In an effort to overcome those problems, APA will launch the newly designed 
definition for ID in the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5). 
This manual will be available in the middle of 2013. However, the online version can be 
accessed on their official website (American Psychiatric Association, 2012). The 
proposed definition is described below: 
General introduction and outline of the thesis 
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Intellectual Developmental Disorder (IDD) is a disorder that includes both a current 
intellectual deficit and a deficit in adaptive functioning with onset during the 
developmental period. The following 3 criteria must be met: 
A.  Intellectual Developmental Disorder (IDD) is characterized by deficits in 
general mental abilities such as reasoning, problem-solving, planning, 
abstract thinking, judgment, academic learning and learning from 
experience. 
B.  Impairment in adaptive functioning for the individual’s age and 
sociocultural background. Adaptive functioning refers to how well a person 
meets the standards of personal independence and social responsibility in 
one or more aspects of daily life activities, such as communication, social 
participation, functioning at school or at work or personal independence at 
home or in community settings. The limitations result in the need for 
ongoing support at school, work, or independent life. Independent life 
requires self-management across life settings such as personal care, job 
responsibilities, financial management, recreation, managing one’s 
behaviour, and organizing school and work tasks. 
C.  All symptoms must have an onset during the developmental period. 
 From the definition described above, the main changes are:  
1. Name changing. The term mental retardation was used in earlier DSM 
definitions including the currently used DSM-IV-TR. Nowadays, that term 
is no longer used and changed into Intellectual Disability (ID). In order to 
conform International Classification of Diseases (ICD) by World Health 
Organization (WHO), and as it is thought that ID is a functional disorder, 
the new name, IDD, is proposed (American Psychiatric Association, 2012). 
2. IQ testing  
In order to meet the criteria of the proposed ICD-11, the DSM-5 proposal 
does not list IQ test score requirements in the formal diagnostic criteria. 
This adjustment is necessary to focus on the clinical entity of IDD. 
Furthermore, the IQ test score has often been used improperly to identify a 
person’s overall ability particularly in forensic cases without adequately 
considering adaptive functioning. Nevertheless, DSM-5 proposal continues 
to specify that standardized psychological testing must be included in the 
assessment of affected persons (American Psychiatric Association, 2012). 
3. Onset 
The onset is no longer strictly below 18 years old but symptoms should be 
present during the developmental period. However, there is no further 
explanation. 
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The prevalence of ID across countries and regions ranges from 2 to 85/1000 
(Roeleveld et al., 1997). This range is much more obvious for mild ID (IQ 70–50) than 
for severe ID (IQ<50) (Ropers, 2010). In many studies, the prevalence of ID (IQ<70) 
has been estimated as being close to 3% worldwide (Leonard and Wen, 2002; Ropers, 
2010). This figure might be particularly true for Western countries such as USA and 
European countries. In developing countries, the prevalence of ID is likely to be higher 
(Durkin, 2002). This observation has been attributed to a variety of non-genetic factors. 
In addition, parental consanguinity is identified as another important aetiological factor, 
which is particularly true in countries where consanguinity is still a common practice 
(Durkin, 2002). These factors make the prevalence of ID in the developing countries 
approximately two to threefold higher than in high income countries. It has to be 
considered that, in low income countries, such factors remain as a contributing causes 
of ID; however, these factors are largely prevented in developed countries (Ropers, 
2010).  
There are a number of differences in the reported prevalence of ID. This is 
likely occurred due to differences in the ascertainment of sources and methods 
(Leonard and Wen, 2002). First, the lack of consensus in conceptualization, 
classification and terminology are plausible factors which contribute to these 
differences (Fryers, 1992). Second, various methods of measuring IQ level (IQ tests) 
might also play a role in the variation. Third, ID is often under-detected particularly 
when it is associated with neuropsychiatric disorders such as epilepsy, schizophrenia 
and autism (Ropers, 2010). Finally, a contributing source of the variation could be 
because of prevalence estimation from population screening was steadily higher than 
those actually obtained in registers (Ropers, 2010).  
1.1.2 Aetiology of intellectual disability 
Establishing the aetiology of ID is of great benefit for management and genetic 
counselling of affected individuals and their families. A proper diagnosis may lead to 
appropriate management, early screening for co-morbidity and prevention of 
unnecessary tests; family members may take advantage of knowledge of the 
recurrence risk, availability of reproductive counselling and possible prenatal diagnosis. 
The aetiology of ID is complex and includes a wide range of factors such as 
biochemical/metabolic defects, chromosomal abnormalities, mutations in single genes, 
multifactorial disorders with a polygenic predisposition, and non-genetic causes 
(Chiurazzi and Oostra, 2000; van Karnebeek et al., 2005). There are various non-
genetic factors associated with ID, such as the lack of maternal education, iodine 
deficiency in the mother or child, absence/lack of adequate prenatal and/or perinatal 
care, neonatal infection, lack of immunization, postnatal brain infection, postnatal 
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traumatic brain injury and malnutrition (Durkin, 2002). Apparently, these factors play a 
role as causes of ID in Indonesia. Although there is no clear data of their contribution, 
the prevalence of these factors in the society is still quite high compared to other 
countries. For instance, there are some large areas with iodine deficiency (Hussein, 
1998). Equally, neonatal infection and malnutrition rates are high (Thaver and Zaidi, 
2009; Pakasi et al., 2009; Oddo et al., 2012). Furthermore, pre-, peri-, and postnatal 
care is poor (Titaley et al., 2010) and low birth-weight commonly occurs (Amiruddin and 
Yusuf, 2008).   
It has been estimated that at least 60% of ID cases have an underlying genetic 
aetiology (Battaglia and Carey, 2003; Lundvall et al., 2012). This is particularly true in 
cases of moderate-severe ID where a single recognizable factor is more often present 
(Flint and Wilkie, 1996; Lundvall et al., 2012). On the other hand,  most  of the cases 
with mild ID are generally thought to be the result of the interaction of genetic and non-
genetic factors (Patel et al., 2010; van Bokhoven, 2011). That explains why  nearly 60% 
of the individuals with ID remain without a proper diagnosis, even after intensive 
investigations (Moog, 2005; Patel et al., 2010; Pfundt and Veltman, 2012). 
A comprehensive study on the aetiology was performed in 10,997 ID 
individuals by Stevenson et al. (2003). Specific causes for ID were found in 43.5% 
(summarized in Table 1.2.). In 2006, a study on the diagnostic yield of various genetic 
approaches involving 670 patients with DD/ID generated an abnormality detection rate 
of up to 40% (Rauch et al., 2006). The abnormalities detected in this study are 
summarized in Table 1.3. Since then, no similar large scale studies have been 
reported. Although the above studies provide a general idea on the frequencies of the 
main causative categories, the incidences might have changed now. Advanced 
technologies (high-throughput and/or high-resolution) being used to detect genetic 
abnormalities have facilitated the detection of many new syndromes and genetic 
defects. Therefore, an update on the detection rate including these novel techniques is 
required in the near future. 
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Table 1.2. Aetiology of intellectual disability adapted from Stevenson et al. (2003). 
Aetiology Frequency 
Chromosomal  11.1%  
Single gene  7.8%  
Culturofamilial *) 5.5% 
Multifactorial  1.8%  
Injury  4.8%  
Infection  4.7% 
Prematurity  4.5%  
Chemical  1.5%  
Other genetic syndromes  0.8%  
Syndromes presumed to be genetic  0.6%  
Other environmental  0.4%  
Unknown  56.5% 
Total 100% 
*) both culturofamilial and  multifactorial were described to be the conditions caused by a combination of 
genetic and environmental factors (Stevenson et al., 2003). The distinguishing boundary between the 
two is not obviously clear. The term “culturofamilal” must be used with caution and awareness of its 
limitations as it does lack causality and clarity (Moog, 2005). 
 
Table 1.3. Diagnostic yield of various methods in DD/ID population adapted from 
Rauch et al. (2006) 
Genetic aetiology Frequency 
Numerical chromosome abnormalities 11.3%  
Array technique  6.6 % 
Microdeletion syndromes 5.3% 
Monogenic 4.8% 
Segmental chromosome aneusomy 4.7% 
Mendelian 2.7% 
Clinical recognizable syndromes 1.3% 
Exogenic 1.3% 
Submicroscopic subtelomeric 1.3% 
Balanced translocations 0.6% 
Mosaic trisomies 0.6% 
Uniparental disomy (UPD) 0.3% 
Unknown  59.2% 
Total 100% 
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In recent years, new techniques allowed the discovery of numerous new 
monogenic disease genes as well as submicroscopic deletion and duplication 
syndromes  (Mefford, 2009; Ropers, 2010; Mefford et al., 2012). By combining the 
targeted high-resolution approach of the fluorescence in situ hybridization (FISH) 
technology and the whole-genome approach of karyotyping, the DNA microarray 
technologies led to a significant change of human genome analysis (Pfundt and 
Veltman, 2012).  
The most important platforms to detect copy number variants are comparative 
genome hybridization (CGH) array and single nucleotide polymorphism (SNP) arrays. 
The first array CGH experiments in patients with ID and dysmorphic features were 
based on the use of homemade DNA from bacterial artificial chromosome (BACs) 
spotted on glass slides (Vissers et al., 2003). Nowadays, a range of oligonucleotide-
based SNP microarrays are commonly used to replace the BAC based arrays that have 
largely disappeared (Schaaf et al., 2011). The DNA microarray technology has proven 
to be successful to define new submicroscopic aberration syndromes. The use of 
chromosomal micro array (CMA) has a greater diagnostic yield than routine G-banded 
karyotyping (Sagoo et al., 2009; Miller et al., 2010). Therefore, the International 
Standard Cytogenomic Array (ISCA) Consortium as well as American Society of 
Human Genetics (ASHG) and European Society of Human Genetics (ESHG) 
suggested the use of CMA as the first tier cytogenetic diagnostic test for patients with 
developmental delay (DD)/ID, autism and multiple congenital anomalies (MCA), while 
the G-banded karyotyping and FISH should be kept for patients with obvious 
chromosomal syndromes (i.e. Down syndrome), a history of multiple miscarriages and 
a family history of a chromosomal rearrangement (Miller et al., 2010). Still, these 
techniques are solely meant for the detection of chromosomal imbalances and are not 
suitable for the detection of most monogenic causes of ID. 
Lately, a new technique named massive parallel sequencing (MPS) or next 
generation sequencing (NGS) enables sequencing of millions of DNA fragments in a 
parallel fashion, allowing the possibility to detect all kinds of genomic variation in a 
single experiment (Gilissen et al., 2012). One of the most promising new methods for 
disease gene identification utilizing the NGS technology is exome sequencing. Exome 
sequencing allows the study of the protein-coding part of the genome from an individual 
in a single experiment (Vissers, 2010a; Gilissen, 2012; Majewski, 2012). 
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1.1.3. Genetic causes of intellectual disability 
Chromosomal abnormalities 
 
Pathogenic chromosomal abnormalities are considered to be the most 
common genetic cause of ID (Stevenson et al., 2003; Rauch et al., 2006; Lundvall et 
al., 2012). After the fundamental discovery that normal human cells contained 46 
chromosomes in 1956 (Tjio and Levan, 1956), it was later followed by identification of 
numerical chromosome aberrations in individuals with ID/MCA such as Down syndrome 
(trisomy 21) (LeJeune et al., 1959), Turner syndrome (45,X) (Ford et al., 1959), 
Klinefelter syndrome (47,XXY) (Jacobs and Strong, 1959), Patau syndrome (trisomy 
13) (Patau et al., 1960) and Edward syndrome (trisomy 18) (Edwards et al., 1960). In 
addition, several chromosomal abnormalities like unbalanced translocations, 
supernumerary marker chromosomes and large (>5 Mb) deletions and duplications 
were later identified and recognized as causes of ID (Smeets, 2004). The 
microscopically visible numerical and structural abnormality rates vary considerably 
among different studies. A rate between 7–56% was reported, reflecting differences 
between techniques and patient selection (van Karnebeek et al., 2002; Dayakar et al., 
2010). In a large meta-analysis, a median rate of 9.5% was found (van Karnebeek et 
al., 2005).  
Down syndrome (trisomy 21) is the most common classical chromosomal 
aneuploidy causing ID. It is the most frequent genetic form of ID with a relatively 
constant frequency of 9-12% (Leonard and Wen, 2002; Stevenson et al., 2003). The 
prevalence of other microscopically visible aberrations is less common. If patients with 
Down syndrome were excluded, the cumulative frequency of such aberration is fewer 
than 5% (Rauch et al., 2006; Miller et al., 2010; Lundvall et al., 2012).  
During the last decade, molecular techniques became available to identify 
submicroscopic cytogenetic abnormalities (Trask, 2002; Smeets, 2004). FISH, targeted 
qualitative Polymerase Chain Reaction (qPCR) and Multiplex Ligation-dependent Probe 
Amplification (MLPA) allowed identification of submicroscopic rearrangements (Flint et 
al., 1995; Knight et al., 1999; Schouten et al., 2002; Hoebeeck et al., 2005). Some 
common cryptic rearrangements lead to recurrent submicroscopic abnormalities such 
as Prader-Willi and Angelman syndromes (15q11.2-q13), Williams-Beuren syndrome 
(7q11.23), Smith-Magenis syndrome (17p11.12) and DiGeorge syndrome (22q11.2) 
(Shaffer et al., 2007a; Gropman and Batshaw, 2010). The prevalence of such 
abnormalities was estimated to be about 4% (Rauch et al., 2006).  
Apart from those common cryptic rearrangements, segmental aneusomies are  
a common cause of ID and about half of these include a telomere (Biesecker, 2002).  
After Flint et al. (1995) found subtelomeric microdeletions using FISH in unrelated 
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patients with ID and helped by the upcoming availability of molecular probes specific for 
the region, many studies attempted to determine the prevalence of such conditions in 
the ID population (Knight et al., 1999; Baker et al., 2002). Biesecker reviewed 14 
previously reported studies with different methods and ascertainment involving 1718 
subjects that performed submicroscopic subtelomeric analysis from 1995-2002. That 
review generated a mean abnormality rate of 6% with a range of 2–29% in individual 
studies (Biesecker, 2002). Several studies later identified an abnormality rate of 
subtelomeric submicroscopic rearrangements in the range of 5-9% (Christofolini et al., 
2010; Wu et al., 2010; Jehee et al., 2011).  
Various assays such as FISH, MLPA and qPCR to identify smaller cytogenetic 
abnormalities, however, are limited to specific regions, e.g. subtelomeric region, and 
cannot identify submicroscopic imbalances elsewhere. DNA microarray technology 
combines the targeted high resolution approach of FISH/MLPA/qPCR technology and 
the whole genome approach of conventional karyotyping technology (Vissers et al., 
2010b; Pfundt and Veltman, 2012). Therefore, it allows the detection of submicroscopic 
genomic variation at a resolution far below 5 Mb as well as enables wide screening for 
submicroscopic rearrangements (Menten et al., 2006; Bejjani and Shaffer, 2006).  This 
new technology has led to an aetiological diagnosis in another ~14% of ID cases (Miller 
et al., 2010; Cooper et al., 2011). Nowadays, the DNA microarray technology 
supersedes the use of conventional karyotyping and other previous assays such as 
FISH, MLPA and qPCR in diagnostic laboratories in western countries. This 
technology, however, is hardly available in developing countries such as Indonesia. 
Submicroscopic interstitial chromosomal imbalances are responsible for a 
considerably number of ID cases. Such rearrangements involve chromosomal 
deletions/duplications that span several genes but are too small to be detected using 
conventional cytogenetic analysis (Shaffer et al., 2007a). These few common 
rearrangements in this size-range are also referred to chromosome 
microdeletion/microduplication genomic disorders (Lupski, 2009; Vissers and 
Stankiewicz, 2012). Apart from deletions and duplications, such rearrangements may 
include insertions, inversions and balanced translocations. These rearrangements are 
caused by regional genomic architecture which may lead to the gain or loss of a 
dosage sensitive gene (or genes) or disruption of a gene (or genes) (Vissers et al., 
2009).  There are three major underlying mechanisms that may lead to copy number 
changes namely non-allelic homologous recombination (NAHR), non-homologous end 
joining (NHEJ) and fork stalling and template switching (FoSTes) (Hastings et al., 2009; 
Lupski, 2009; Zhang et al., 2009). Overall, such rearrangements fall into two 
categories, namely recurrent and non-recurrent aberrations. While recurrent 
rearrangements are characterized by a common size and clustered breakpoints, non-
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recurrent ones are usually unique and spread over a certain genomic region (Vissers et 
al., 2009). 
Formerly, recognition of submicroscopic aberration syndromes relied on 
identification of chromosome abnormalities in a collection of patients with a common 
phenotype and delineation of a critical genomic region due to an initial observation of a 
balanced or unbalanced translocation (Shaffer et al., 2007a). For such rearrangements, 
identification of the cytogenetic origin was first established by detection of a common 
aberration in a cohort of individuals with similar phenotypic features, e.g. the 
identification of 15q12 deletion in Prader–Willi syndrome (Ledbetter et al., 1981). The 
other famous examples include Williams-Beuren and Miller-Dieker syndrome (Dobyns 
et al., 1983; Ewart et al., 1993; Lowery et al., 1995; Brewer et al., 1996). Nowadays, the 
opportunity to perform genome wide copy number variation (CNV) analysis in 
individuals with ID has significantly increased the possibility to find new submicroscopic 
aberration syndromes (Shaffer et al., 2007a; Shaffer et al., 2007b). This led to a shift 
from a “phenotype first” to a “genotype first” or “reverse phenotypic” approach in which 
patients are identified by a similar genomic aberration before a common clinical 
presentation is defined (Shaffer et al., 2007b). Several submicroscopic aberration 
syndromes associated with ID and/or related disorders are summarized in Table 1.4. 
 
Table 1.4. Several submicroscopic aberration syndromes associated with ID 
and/or related disorders (adapted from Ropers, 2010; Vissers et al., 2010b; 
Vissers and Stankiewicz, 2012) 
Genomic 
region/name 
MIM Region 
of 
overlap 
(Mb) 
Clinical features Selected 
references 
1q21 
microdeletion 
612474 1.2 Mild to moderate intellectual 
disability, schizophrenia, 
autism, microcephaly, 
cataracts, cardiac 
abnormalities 
(Mefford et al., 2008; 
Stefansson et al., 
2008) 
1q21 
microduplication 
612475 1.2 Risk factor for intellectual 
disability and autism spectrum 
disorder, macrocephaly, 
congenital abnormalities 
(Szatmari et al., 2007; 
Brunetti-Pierri et al., 
2008) 
2p15p16.1 612513 4.0 Moderate to severe intellectual (Rajcan-Separovic et 
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Genomic 
region/name 
MIM Region 
of 
overlap 
(Mb) 
Clinical features Selected 
references 
microdeletion disability, microcephaly, optic 
nerve hypoplasia, 
hydronephrosis, facial 
abnormalities, feeding 
problems, camptodactyly 
al., 2007; de Leeuw et 
al., 2008) 
3q29 
microdeletion 
609425 1.8 Mild to moderate intellectual 
disability, autism, 
microcephaly, dysmorphic 
facial features, ataxia, chest 
wall deformity, long tapering 
fingers 
(Willatt et al., 2005; 
Ballif et al., 2008) 
3q29 
microduplication 
611936 1.8 Mild to moderate intellectual 
disability, microcephaly, 
ophthalmological problems 
(Ballif et al., 2008; 
Goobie et al., 2008; 
Lisi et al., 2008) 
5q35 
microdeletion 
(Sotos 
syndrome) 
117550 2.3 Intellectual disability, severe 
learning disabilities, 
overgrowth, macroencephaly, 
dysmorphic face 
(Kurotaki et al., 2005; 
(Tatton-Brown et al., 
2005) 
7q11.23 
microdeletion 
(Williams–
Beuren 
syndrome) 
194050 1.5 Intellectual disability, short 
attention span, aortic stenosis, 
small teeth, facial 
abnormalities, hernias 
(Grimm and 
Wesselhoeft, 1980; 
Tassabehji, 2003) 
7q11.23 
microduplication
/triplication 
609757 1.5 Mild intellectual disability, 
autism, speech delay, seizures 
type II trigonocephaly, cortical 
dysplasia, growth retardation 
(Somerville et al., 
2005; Depienne et al., 
2007; Torniero et al., 
2008) 
8p23.1 
microdeletion 
syndrome 
 3.6 Intellectual disability, 
hyperactivity, congenital hernia 
of diaphragm, heart defects, 
cryptorchid testes 
(Faivre et al., 1998) 
9q22.3 
microdeletion 
 6.5 Intellectual disability, 
hyperactivity, psychomotor 
(Redon et al., 2006) 
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Genomic 
region/name 
MIM Region 
of 
overlap 
(Mb) 
Clinical features Selected 
references 
delay, macrocephaly, 
trigonocephaly, facial 
abnormalities, overgrowth 
15q11.2 
microdeletion 
 0.3 Risk factor for epilepsy (de Kovel et al., 2010) 
15q13.1 
microduplication 
  Intellectual disability, 
schizophrenia, autism 
 
(van Bon et al., 2009; 
de Kovel et al., 2010) 
15q13.3 
microdeletion 
612001 1.5 Risk factor for intellectual 
disability, schizophrenia, 
autism, and epilepsy, facial 
abnormalities, clinodactyly 
(Sharp et al., 2008; 
Dibbens et al., 2009; 
Helbig et al., 2009) 
15q24 
microdeletion 
613406 1.5 Mild intellectual disability, 
growth retardation, 
microcephaly, digital 
abnormalities, hypospadias, 
loose connective tissue, facial 
abnormalities 
(Sharp et al., 2007; 
Klopocki et al., 2008) 
15q24 
microduplication 
613406 1.5 Developmental delay, 
dysmorphic facial features, 
digital and genital 
abnormalities 
(Kiholm Lund et al., 
2008) 
16p11.2 
microdeletion 
611913 0.7 Intellectual disability, autism, 
developmental disorder, motor 
delay, seizures, behavioral 
problems, speech delay, 
macrocephaly, congenital 
abnormalities 
(Weiss et al., 2008; 
Shinawi et al., 2010) 
16p11.2 
microduplication 
611913 0.7 Schizophrenia, bipolar 
disorder, autism, motor delay, 
speech delay, ADHD, 
microcephaly, congenital 
abnormalities 
(Weiss et al., 2008; 
McCarthy et al., 2009; 
Shinawi et al., 2010) 
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Genomic 
region/name 
MIM Region 
of 
overlap 
(Mb) 
Clinical features Selected 
references 
16p11.2p12 
microdeletion 
 7.1 Intellectual disability, recurrent 
ear infection, minor facial 
abnormalities, feeding 
difficulties 
(Ballif et al., 2007; 
Ghebranious et al., 
2007; Hempel et al., 
2009) 
16p13.1 
microdeletion 
 1.5 Intellectual disability, risk factor 
for epilepsy and schizophrenia, 
dysmorphic features 
(Ullmann et al., 2007; 
Hannes et al., 2009; 
de Kovel et al., 2010) 
16p13.1 
microduplication 
 1.5 Risk factor for intellectual 
disability, autism, and 
schizophrenia 
(Ikeda et al., 2010; 
Ingason et al., 2011) 
17p13.3 
microdeletion 
(LIS1 gene) 
  Intellectual disability, epilepsy, 
lissencephaly 
(Mei et al., 2008) 
17p11.2 
microdeletion 
(Smith–Magenis 
syndrome) 
182290 3.5 Intellectual disability, 
hyperactivity, self-mutilation, 
sleep disorder, hoarse voice, 
brachydactyly, hypotonia 
(Chen et al., 1997) 
17p11.2 
microduplication 
(Potocki–Lupski 
syndrome) 
610883 3.8 Mild intellectual disability, 
ADHD, autism, infantile 
hypotonia, failure to thrive, 
sleep apnea, cardiovascular 
abnormalities 
(Potocki et al., 2000; 
Potocki et al., 2007) 
17q11.2 
microdeletion 
(NF1 gene) 
613675 1.4 Intellectual disability, patchy 
skin pigmentation, 
hypertelorism, coarse facial 
features 
(Dorschner et al., 
2000; Kluwe et al., 
2004) 
17q12 
microdeletion 
614527 1.4 Intellectual disability, renal 
phenotype, elevated liver 
enzymes, maturity-onset 
diabetes of the young (MODY) 
(Muller et al., 2006; 
Mefford et al., 2007) 
17q12 
microduplication 
614526 1.4 Risk factors for mild to 
moderate intellectual disability 
and epilepsy 
(Mefford et al., 2007) 
Chapter 1 
26 
 
Genomic 
region/name 
MIM Region 
of 
overlap 
(Mb) 
Clinical features Selected 
references 
17q21.31 
microdeletion 
610443 0.6 Intellectual disability, learning 
disabilities, neonatal 
hypotonia, heart defects, 
kidney defects, coarsening of 
facial features with age, 
oromotor dyspraxia 
(Sharp et al., 2006; 
Koolen et al., 2006; 
Shaw-Smith et al., 
2006) 
17q21.31 
microduplication 
613533 0.6 Intellectual disability, severe 
psychmotor developmental 
delay, poor social interaction, 
microcephaly, abnormal digits, 
hirsutism, facial dysmorphism 
(Kirchhoff et al., 2007; 
Grisart et al., 2009) 
22q11 
microdeletion 
611867 0.6 Mild learning disabilities, 
speech delay, schizophrenia, 
heart defects, renal 
abnormalities, neonatal 
hypocalcemia, velopharyngeal 
insufficiency, facial 
abnormalities 
(Ryan et al., 1997) 
22q11 
microduplication
/triplication 
608363 3.0 Intellectual disability, learning 
disabilities, growth retardation, 
muscular hypotonia, delayed 
psychomotor development 
(Ensenauer et al., 
2003; Yobb et al., 
2005; Wentzel et al., 
2008) 
22q11.21-
q11.23 
microdeletion 
611867  Intellectual disability, facial 
abnormalities, growth delay, 
cardiovascular malformation, 
mild skeletal abnormalities 
(Ben-Shachar et al., 
2008) 
22q11.21-
q11.23 
microduplication 
608363  Intellectual disability, no 
speech or speech delay, no 
walking, apraxia and dysartria, 
facial abnormalities 
(Mefford et al., 2009; 
Coppinger et al., 2009) 
 
22q13 
microdeletion 
606232 0.1 Global developmental delay, 
absent to severely delayed 
speech, autistic-like behavior, 
(Phelan, 2008; Mefford 
et al., 2009) 
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Genomic 
region/name 
MIM Region 
of 
overlap 
(Mb) 
Clinical features Selected 
references 
minor dysmorphic features 
Xp22.31 
microdeletion 
308100  Intellectual disability, X-linked 
ichthyosis 
(van Esch et al., 
2005b) 
Xp22.31 
microduplication 
  Intellectual disability, speech 
delay, microcephaly 
(Wagenstaller et al., 
2007) 
Xq28 
microduplication 
 0.4-0.8 Severe intellectual disability, 
severe hypotonia, speech 
delay, seizures, recurrent 
infections 
(van Esch et al., 
2005a) 
 
X-Linked intellectual disability  
The excessive number of males over females among all severities of ID has 
been noticed since a long time ago. The difference is ranging from 30% to 50% and is 
consistent among various populations. This suggests that X-linked genes play a role in 
the aetiology of ID (Hussein, 1998; Ropers and Hamel, 2005; Lundvall et al., 2012). In 
the early 1930s, the investigation referred as Colchester Survey revealed that males 
outnumbered females among a wide range of ID population. This study included 1280 
institutionalized individuals with all severities of ID (Penrose, 1938; Morton et al., 1977). 
In the 1940s, Martin and Bell described a condition with “sex-linked” ID which is now 
known to be FXS. Such investigation illustrated that “sex-linked” inheritance was the 
explanation for the presence of ID in a two generations family with 11 affected males 
(Martin and Bell, 1943). In the early of 1970s, Lehrke was the first to argue for the 
existence of major genes related to intellectual function situated on the X chromosome. 
In addition, Lehrke put forward the four hypotheses: i) there are major genetic loci 
associated with human intellectual functioning which are located in the X chromosome; 
ii) mutation on these genes can lead to subnormal intellectual function; iii) one or more 
of these genes is particularly associated to verbal functioning; and iv) the deficit links 
primarily to the central nervous system (Lehrke, 1972; Lehrke, 1974).  
Still in the 1970s, the publication of the first family with the marker X by Lubs et 
al.  (1969) gave an important momentum to the field by offering a laboratory tool which 
clearly identified the most prevalent XLID syndrome (Lubs, 1969). Several years later, 
linkage studies revealed that the location of the marker chromosome (fragile site) 
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overlapped with the map position of underlying genetic defect (Verkerk et al., 1991). 
These findings paved the way for molecular elucidation of the FXS and since then FXS 
remained the centre of research into ID which triggered the findings of other XLID 
genes (Ropers, 2010; Lubs et al., 2012).  
In the past decade, X chromosome sequencing, DNA microarrays technology 
and exploration of molecular pathways have enhanced the elucidation of even more 
XLID genes (Gecz et al., 2009; Lubs et al., 2012). The application of powerful DNA 
microarray technology in combination with various molecular technologies has 
progressively been used to identify duplications and deletions of genes associated with 
XLID (Froyen et al., 2007; Tarpey et al., 2009; Whibley et al., 2010; Gijsbers et al., 
2011). Up to now, more than 150 syndromes associated with XLID have been 
described, with FXS as the most common one (Lubs et al., 2012; Stevenson et al., 
2012). In addition, a total of 95 families with NS-XLID has been regionally mapped.  
Furthermore, mutations in 102 X-linked genes have been associated with 81 out of 160 
XLID syndromes as well as 50 families with NS-XLID. Moreover, an additional 30 XLID 
syndromes and 48 families with nonsyndromal XLID have been regionally mapped in 
which the genes have not yet been identified (Lubs et al., 2012).  
Autosomal forms of intellectual disability 
Since X-linked forms account for only 10-15% of ID cases, the vast majority of 
the underlying genetic defects are believed to be autosomal either dominant 
(autosomal dominant ID; ADID) or recessive (autosomal recessive ID; ARID) (Ropers, 
2010; van Bokhoven, 2011). It is estimated that more than 800 genes associated with 
ID are located in the autosomes (Ropers, 2010). For several reasons, the elucidation of 
these autosomal genes has been lagging far behind the XLID. The major reason is the 
lack of suitable families for accurate mapping of genetic defects. Lately, significant 
progress in elucidating autosomal ID genes has been made. However, still little is 
known about the gene defects underlying these autosomal forms (Ropers, 2010; van 
Bokhoven, 2011). Families with autosomal dominant inheritance are rare since affected 
individuals in general will not reproduce. Strategies to identify autosomal dominant 
genes, therefore, direct to the identification of de novo mutations (Ropers, 2007). 
Until 2007, no more than twelve loci had been mapped for nonsyndromic ARID 
(Basel-Vanagaite, 2007). In addition, only three genes had been identified, namely 
PRSS12 (Molinari, 2002), CRBN (Higgins et al., 2004), and CC2D1A (Basel-Vanagaite 
et al., 2006), all in large consanguineous families. Nowadays, several strategies to 
elucidate the molecular defects underlying ARID have been utilized. For instance, 
homozygosity mapping in large consanguineous families followed by mutation 
screening of candidate genes has been employed to identify several gene defects of 
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ARID (Ropers, 2007). In general, this strategy will identify one or a few regions of 
shared homozygous haplotypes, ranging from a few to several Mb per family (van 
Bokhoven, 2011). Another strategy is using a massive parallel sequencing approach. 
This recent innovation has expedited the successful identification of causative 
mutations in autosomal ID (van Bokhoven, 2011). Recently, by combining 
homozygosity mapping, exon enrichment and NGS in 136 consanguineous families 
with ARID, 50 novel candidate genes for ARID have been revealed (Najmabadi et al., 
2011). This study is the largest published so far in the field of autosomal form of ID. 
De novo mutations refer to mutations which occur in the gametes of the 
parents during meiosis. It is estimated that humans have an exceptionally high per-
generation mutation rate of between 7.6×10−9 and 2.2×10−8
Table 1.5 De novo mutations underlying rare syndromic ID identified by whole-
exome sequencing studies (adapted from Ku et al., 2012)  
. Therefore, it is calculated 
that an average newborn would acquire 50–100 new mutations in his or her genome 
(Roach et al., 2010; Lynch, 2010).  The study of de novo point mutations remained 
stagnant until the advent of NGS. Vissers et al. (2010a) first demonstrated, by using a 
family based whole-exome sequencing (WES - sequencing of all the exons in the 
genome) approach, that de novo mutations are a common cause of ID. Ten case-
parent trios were sequenced in order to investigate potentially pathogenic de novo 
changes in the exome sequences of the affected offspring with otherwise normal 
karyotype and array-based genome profiling. In addition to ID, de novo mutations have 
also been found to have an important role in other neurodevelopmental disorders such 
as autism (O'Roak et al., 2011) and schizophrenia (Xu et al., 2011). Subsequently, a 
number of de novo mutations underlying mendelian rare disorders associated with 
neurodevelopmental defects were identified using WES technology (summarized in 
Table 1.5).  
Disorder MIM Associated clinical 
features 
Gene References 
Kabuki syndrome    147920 Mild-to-moderate 
intellectual disability, 
distinctive facial 
appearance, cardiac 
anomalies, skeletal 
abnormalities and 
immunological defects.  
MLL2  (Ng et al., 
2010) 
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Disorder MIM Associated clinical 
features 
Gene References 
Schinzel–Giedion 
syndrome  
  269150 Severe intellectual 
disability, distinctive facial 
features and multiple 
congenital malformations 
(including skeletal 
abnormalities, genitourinary 
and renal malformations 
and cardiac defects).  
SETBP1 (Hoischen et 
al., 2010) 
Bohring–Opitz 
syndrome  
  605039 Severe intellectual 
disability, prominent 
metopic suture, 
exophthalmus, forehead 
nevus flammeus, upslanting 
palpebral fissures, ulnar 
deviation and flexion of the 
wrists and 
metacarpophalangeal 
joints, and severe feeding 
problems. 
ASXL1 (Hoischen et 
al., 2011) 
Say-Barber-
Biesecker-Young-
Simpson 
syndrome / Ohdo 
syndrome  
  603736 Severe intellectual 
disability, 
blepharophimosis, a mask-
like facial appearance, 
thyroid abnormalities and 
cleft palate. 
KAT6B (Clayton-Smith 
et al., 2011) 
Hypothyroidism    614450 Hypothyroidism (growth 
retardation, develop 
intellectual disability, 
skeletal dysplasia and 
severe constipation) but 
only borderline-abnormal 
thyroid hormone levels. 
THRA  (Bochukova et 
al., 2012) 
Genitopatellar 
syndrome 
  606170 Severe intellectual 
disability, patellar aplasia or 
KAT6B (Campeau et 
al., 2012; 
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Disorder MIM Associated clinical 
features 
Gene References 
hypoplasia and external 
genital anomalies. 
Simpson et al., 
2012) 
KBG syndrome    148050 Intellectual disability, 
macrodontia of the upper 
central incisors, distinct 
craniofacial findings, short 
stature and skeletal 
anomalies. 
ANKRD11  (Sirmaci et al., 
2011) 
Weaver syndrome    614421 Generalized overgrowth, 
advanced bone age, 
marked macrocephaly, 
hypertelorism and 
characteristic facial 
features. Intellectual 
disability is common. 
EZH2 (Gibson et al., 
2012) 
Floating-Harbor 
syndrome  
  136140 Short stature, delayed 
osseous maturation, 
expressive-language 
deficits and a distinctive 
facial appearance. 
SRCAP  (Hood et al., 
2012) 
Hereditary diffuse 
leukoencephalo-
pathy with 
spheroids 
  221820 White-matter abnormality 
and variable clinical 
presentations (personality 
and behavioural changes, 
dementia, depression, 
parkinsonism, seizures and 
other phenotypes). 
CSF1R  (Rademakers 
et al., 2012) 
Coffin–Siris 
syndrome  
  135900 Developmental delay, 
severe speech impairment, 
coarse facial features, 
hypertrichosis, hypoplastic 
or absent fifth fingernails or 
toenails and agenesis of the 
corpus callosum. 
ARID1B 
SMARCB1  
(Tsurusaki et 
al., 2012; 
Santen et al., 
2012) 
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Disorder MIM Associated clinical 
features 
Gene References 
Olmsted 
syndrome  
  607066 Bilateral mutilating 
palmoplantar keratoderma 
and periorificial keratotic 
plaques with severe itching 
at all lesions. 
TRPV3  (Lin et al., 
2012) 
Baraitser–Winter 
syndrome 
614583 
243310 
Intellectual disability, 
seizures, hearing loss, 
congenital ptosis, high-
arched eyebrows, 
hypertelorism, ocular 
colobomata and a brain 
malformation consisting of 
anterior predominant 
lissencephal, postnatal 
short stature and 
microcephaly. 
ACTB  
ACTG1 
(Riviere et al., 
2012) 
Autosomal-
dominant 
cerebellar ataxia, 
deafness and 
narcolepsy 
  604121 Late onset (age 30–40 
years) narcolepsy–
cataplexy, sensory neuronal 
deafness, cerebellar ataxia, 
dementia, psychosis, optic 
atrophy and other 
symptoms. 
DNMT1 (Winkelmann 
et al., 2012) 
Mandibulofacial 
dysostosis with 
microcephaly 
  610536 Craniofacial malformations, 
microcephaly, 
developmental delay, 
recognizable dysmorphic 
appearance, choanal 
atresia, sensorineural 
hearing loss and cleft 
palate. 
EFTUD2  (Lines et al., 
2012) 
Myhre syndrome    139210 Reduced growth, 
generalized muscular 
hypertrophy, facial 
SMAD4 (Caputo et al., 
2012) 
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Disorder MIM Associated clinical 
features 
Gene References 
dysmorphism, deafness, 
cognitive deficits, joint 
stiffness and skeletal 
anomalies. 
 
Metabolic disturbances 
Inborn errors of metabolisms (IEMs) are possible treatable causes of ID (van 
Karnebeek and Stockler, 2012). Using routine metabolic investigations, such causes 
can be identified in 0.2 to 8.4% of ID cases (van Karnebeek et al., 2005; Sempere et 
al., 2010). Moreover, detailed and tailored metabolic assessment yielded causative 
IEMs up to 20% cases  in a population with unexplained neurodevelopmental disorders 
that were referred to a tertiary diagnostic centre (Engbers et al., 2008). To date, there 
are 81 IEMS with ID as a major clinical feature (van Karnebeek and Stockler, 2012). 
Although the prevalence of each of the 81 conditions is considered low, varying from 
1:10,000 – 1:200,000, detection is important because of its possible treatability (van 
Karnebeek and Stockler, 2012). Albeit that evidence for the majority of the therapies is 
limited, it is reported that in clinical practice more than 60% of treatments have 4–5 
evidence level, an internationally accepted level as ‘standard of care’ (van Karnebeek 
and Stockler, 2012). A list of 81 IEMs and its availability of treatment is available in 
www.treatable-id.org.  
1.1.4. Neurobiology of genetically based intellectual disability 
There are several general molecular and cellular mechanisms underlying the 
pathophysiology of genetically based ID. In general, they can be subdivided into two 
groups, those with detectable cortical brain developmental abnormalities and those with 
an apparent normal brain organization (Chelly et al., 2006; Vaillend et al., 2008). In 
many circumstances where detectable developmental brain abnormalities are present, 
ID is a component of a complex syndrome where neurodevelopmental programmes 
and normal organizational patterns of cerebral cortex are disrupted and thus lead to 
developmental brain abnormalities (Chelly et al., 2006; Francis et al., 2006).  In these 
conditions, ID is presumably a secondary symptom (Chelly et al., 2006).  On the 
contrary, for those with an apparent normal brain organization and architecture, ID is 
most likely due to abnormal interaction of neuronal and/or glial cells (Chelly et al., 2006; 
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Vaillend et al., 2008). Mutations in some genes are associated with a variety of different 
Cognitive Disorders (CDs). This may be an explanation for the high comorbidity that is 
commonly observed between ID and other cognitive impairments, such as autism, 
attention deficit hyperactivity disorder (ADHD) and schizophrenia (van Bokhoven, 
2011). 
Functional studies have shown that these genes are involved in 
neurodevelopmental processes and share common signaling pathways, highlighting 
their significance for normal cognitive development. In addition, it is evident that, for 
example, even mild alterations in synapse morphology and function can cause ID 
(Vaillend et al., 2008; van Bokhoven, 2011; Verpelli and Sala, 2011). Interestingly, it 
seems that some pharmacological agents are able to work against these morphological 
and functional anomalies. This may lead to the feasibility of future targeted treatment 
(Vaillend et al., 2008; van Bokhoven, 2011; Verpelli and Sala, 2011).  
1.1.5. Indonesia as a field of study 
The population of Indonesia in 2010 reached 237,641,326 people. Among 
countries with the largest population in the world, Indonesia ranks the fourth after 
China, India, and the United States (Indonesian Central Bureau of Statistics, 2011a). 
To date, there are little data on prevalence and aetiology of ID in Indonesia. There are 
four data sources for the ID individual: Indonesian Central Bureau of Statistics (ICBS), 
the Indonesian Ministry of National Education, the Indonesian Ministry of Social Affairs 
and the Indonesian Ministry of Health. Based on house-to-house direct population 
census, ICBS stated that a total of 4,785,876 (~2% of the population) individuals were 
reported to have difficulties in physical and psychological functioning areas including 
remembering, concentrating, communicating, and taking care of themselves 
(Indonesian Central Bureau of Statistics, 2011b). Among them, 1,149,078 were 
reported to be in severe conditions, requiring full support in all aspects of daily living 
(Indonesian Central Bureau of Statistics, 2011c). The Indonesian Ministry of National 
Education stated that only approximately 66,500 individuals were registered in special 
schools for intellectually disabled (Kemendiknas, 2011). However, this data cannot be 
used to figure out the real prevalence of ID in Indonesia as it does not include the 
number of those staying in formal institutions as well as those not attending school. In 
2010, the Indonesian Ministry of Social Affairs conducted a survey on the basis of ICF 
classification by WHO and found 170,398 ID individuals out of 1,167,111 individuals 
with various disabilities. This figure was determined from only 14 out of 33 provinces 
targeted in the survey (Marjuki, 2010). The data of the Indonesian Ministry of Health in 
the Riset Kesehatan Dasar (Basic Health Research) project in 2007 estimated that the 
national prevalence of mental and emotional impairment is 11.6%, while the prevalence 
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of severe mental disability is 0.46% (Badan Litbangkes Depkes, 2007). This estimation, 
however, was calculated among people aged 15 and over and based on a self-
reporting questionnaire (SRQ). Therefore, it is likely that this figure is inaccurate 
because it does not include those below 15 years old and very likely those with severe 
mental impairment could not participate in the SRQ based survey (Badan Litbangkes 
Depkes, 2007; Badan Litbangkes Kemenkes, 2010). It should be taken into account 
that numerous cases of ID had been overlooked as they were hardly found in the 
registers. For instance, cases of confinement (pemasungan—being captivated in a 
wooden block) of individuals who are intellectually and mentally disturbed are still put 
into practice in some communities (Minas and Diatri, 2008; Tyas, 2008). Furthermore, 
ID individuals are often being vagrant (gelandangan) and live on the streets.   
It is regrettable that in some areas of Indonesia, individuals with ID and their 
families are still being stigmatized. In addition, they frequently receive inadequate 
services or funding (Komardjaja, 2005; Irwanto et al., 2010). Actually, legislation (Law  
No.4/1997) forces private companies and governmental departments to employ 
disabled people. However, this legislation is overlooked because the application, 
enforcement and sanctions of laws and regulations, in general, are weak and easily 
infringed (Republic Indonesia Laws No.4/1997; Komardjaja, 2005; Irwanto et al., 2010). 
ID individuals can be observed in special schools, institutions and special 
dormitories (Komardjaja, 2005). The two latter places are important places for ID 
people to live in and even some parents consider these places as the ‘perfect’ place to 
hide their ID children. Families are often ashamed of having kin with ID (Komardjaja, 
2005). Therefore, hiding their kin with ID in those places is common practice. Some 
individuals with ID ended up their whole lives in those places without being cared for 
and visited by their families (Komardjaja, 2005). In several cases, regrettably, some 
families are no longer in contact with caregivers in those places on purpose and feel no 
longer responsible for their kin anymore. That is why, in particular, the largest budget 
allocation for ID individuals is for social security and food allowance (Irwanto et al., 
2010). Consequently, the relatively small remaining funding is to build infrastructure, 
develop human resources and develop empowerment programmes. Due to the low 
budget, the quality of services turns out to be problematic. One of the apparent 
problems is the unavailability of funding to hire professional care givers (Irwanto et al., 
2010). 
Medical genetics is considered to be a new area in Indonesia. In fact, this field 
grows fast in neighbouring countries of Indonesia such as Singapore and Australia. 
Nowadays, only a few medical geneticists and no clinical geneticist are available in 
Indonesia. Likewise, diagnostic services for genetic abnormalities are rarely found. In 
some big cities on Java Island such as Jakarta, Bandung, Semarang, Yogyakarta and 
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Surabaya, some hospitals / universities offer low resolution karyotyping, mostly limited 
to the diagnosis of numerical chromosomal abnormalities such as Down syndrome and 
sex assignment. The awareness of medical practitioners and specialists related to 
genetics such as paediatricians, neurologists, and obstetricians is still very low. The 
genetic diagnostic services built by government and/or private companies are still 
lagging behind the development of diagnostic facilities for infectious and tropical 
diseases. Concerning individuals with ID, there are only two centres which perform 
comprehensive evaluations:  Eijkman Institute in Jakarta and the Center for Biomedical 
Research (CEBIOR), Faculty of Medicine, Diponegoro University in Semarang. It is 
obvious that the number of clinics, diagnostic facilities and human resources is far too 
small in comparison to the population of Indonesia.  
1.2. Materials and methods 
1.2.1. Patient selection, setting and characteristics 
Prior to this study, our laboratory (Center for Biomedical Research, Faculty of 
Medicine Diponegoro University, Semarang, Indonesia) had been developing some 
collaborations with several schools and institutions within and outside the city of 
Semarang such as Temanggung, Yogyakarta and Bandung. The majority of our 
subjects were from schools and institutions in Semarang due to the proximity to our 
laboratory. As representatives from some other areas were needed as well, subjects 
from Temanggung, Yogyakarta and Bandung were also included. At the time of the 
study, 594 individuals (361 males and 233 females) were registered in those institutions 
(193 individuals) and schools (401 individuals). From this cohort, 527 individuals (329 
males and 198 females) were investigated, leaving 23 individuals who were temporary 
absent and 44 individuals for whom no permission was obtained. A consecutive 
sampling method was used. A standardized and dysmorphological physical 
examination comprising physical measurements and dysmorphological assessment 
has been carried out in all subjects. They were residents of four different places in Java 
Island, Indonesia (Semarang, Temanggung, Gunung Kidul, and Bandung). Out of the 
527 patients, 156 were institutionalized, while 371 came from special schools. Based 
on the IQ data from those schools/institutions, the majority of the individuals (345) 
appeared to be mildly intellectually disabled, while 161 were moderate, and the other 
21 patients were severely intellectually disabled. The information about characteristics 
of the study population is summarized in Table 1.6 
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Table 1.6. Characteristics of the studied population (n = 527)  
Demographic data n  
Gender  
        Male 329 
        Female 198 
Area / City   
        Semarang 327 
        Temanggung 134 
        Yogyakarta   11 
        Bandung   55 
School type  
        Institution 156 
        Special school 371 
ID severity  
        Mild ID 345 
        Moderate ID 161 
        Severe ID  21 
Family history  
        Familial  
        Sibling 10 
        Second cousin 4 
        Sporadic 513 
 
1.2.2. Standardized clinical examination 
A standardized clinical examination protocol adapted from Radboud University 
Nijmegen Medical Centre (RUNMC), Nijmegen was performed by the same clinician 
(Farmaditya EP Mundhofir) and supervised by experienced clinical geneticists from 
RUNMC, Nijmegen. This examination is divided into three parts comprising history 
taking, clinical measurements, and clinical examination including dysmorphological 
assessment. If available, medical history including mental functioning status was 
recorded. History taking comprising pre-, peri-, and postnatal history, pedigree 
construction and developmental history was performed when subjects’ 
parents/caregivers were available. IQ test, either Weschler’s or Binet’s, is compulsory 
for individuals with ID prior to the admission to the special school or institution. For 
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several cases where exact IQ could not be determined, a range of IQ level was 
assigned.  
Physical measurements like weight, height, head circumference (OFC), outer 
canthal distance (OCD), inner canthal distance (ICD), inter pupillary distance (IPD), ear 
length, total hand length (THL), palm length (PL), and - in males - testicular volume 
were documented in all individuals. Some others such as arm span and sitting height 
were performed if there is a suspicion of a specific condition. Clinical examination 
comprised the general habitus and dysmorphological assessment of craniofacial, 
thorax, abdomen, back, genitalia, upper and lower extremities was performed. 
Behaviour including general impression of the personality and some peculiar manners 
such as posture, movement, walking, mimic and stereotypes were observed and 
recorded. Finally, standard clinical pictures were taken from each subject. Due to 
technical and financial constrains, however, some investigations such as metabolic 
investigation and brain imaging were not performed. 
1.2.3. Cytogenetic and molecular investigations 
Peripheral duplicate blood samples in EDTA and Heparin were collected from 
December 2006 to November 2008. Genetic investigations comprising cytogenetic 
analysis, molecular analyses to identify FXS and subtelomeric rearrangements using 
MLPA, and specific tests to identify the presence of specific syndromes (i.e. Prader-
Willi/Angelman syndrome, ID with epilepsy and ID with macro/microcephaly) were 
performed.  
Chromosome cultures and preparations were carried out as described 
elsewhere (Hussein, 1998). One hundred metaphases were screened for fragile sites 
on each sample. Subsequently, chromosome analysis was performed by using G-
banding technique at the level of 400–600 bands. At least 20 metaphases were scored 
for each patient and karyotyped. If a mosaicism was suspected, 50–100 cells were 
counted. MLPA, FISH and SNP array were carried out to confirm the presence of 
cytogenetic abnormalities. 
Genomic DNA of each patient was isolated by using the salting-out method as 
described elsewhere. The CGG repeat in the FMR1 promoter was amplified as 
described by Fu et al. (1991). Fragment length analysis was carried out on an ABI 
Prism 3730 DNA Analyzer (Life Technologies, Foster City, USA), and the Genemapper 
software (version 4.0, Apache) was used to determine the exact length of the CGG 
repeat. Southern blot analysis of the FMR1 CGG(n) repeat was performed as 
previously described (Spath et al., 2010).  
MLPA analysis was performed as described before (Schouten et al., 2002). 
Two probe-kits for subtelomeric chromosomal imbalances were SALSA P070 and 
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SALSA P036D MRC-Holland, Amsterdam, The Netherlands (http://www.mrc-
holland.com). Each subtelomeric rearrangement was identified by at least one 
additional MLPA analysis using the SALSA P070 as the first level screening. 
Afterwards, SALSA P036D was utilized for confirmatory analysis. Fluorescence in situ 
Hybridization (FISH) analysis was performed using commercially available probes 
(Vysis, Inc., Downers Grove, Illinois, USA) according to the manufacturer’s 
recommendations. SNP array analyses were performed using the Affymetrix NspI 250K 
SNP array platform (www.affymetrix.com). Copy number estimates were determined 
using the Copy Number Analyzer for Affymetrix Genechip Mapping (CNAG) software 
package version 2. 
Molecular analyses were performed in subgroups of ID individuals suspected 
of certain genetic abnormalities. There were 13 individuals with clinical suspicion of 
Prader-Willi/Angelman syndrome (PW/AS), in whom molecular analyses were 
performed using MLPA. The SALSA P028 methylation specific probe-kit was utilized, 
which contains probes in the PW/AS region. Two out of these 13 individuals were 
strongly suspected with AS, and therefore additional direct sequencing of UBE3A 
(Angelman syndrome) was performed. In 4 individuals suspected with other specific 
syndromes, direct sequencing of the genes UPF3B and MED12 (Lujan-Fryns 
syndrome), PTEN (Cowden syndrome), TCF4 (Pitt-Hopkins syndrome) and ZEB2 
(Mowat-Wilson syndrome) was carried out. 
In our cohort, there were 31 ID individuals with epilepsy. Direct sequencing of 
the epilepsy genes SCN1A, LGI1, and STXBP1 was performed. Since the ARX gene is 
X-Linked, screening was performed only in 19 male individuals. 
There are 58 ID individuals in our cohort with head circumference/occipital 
frontal circumference (OFC) 
 
abnormalities, including 48 with microcephaly and 10 with 
macrocephaly. For the most prevalent microcephaly genes, ASPM and WDR62, direct 
sequencing was performed in all samples (n=48). Some microcephaly genes such as 
MCPH1, CDK5RAP2, CENPJ, STIL are considered to have a lower prevalence, thus 
direct sequencing was conducted only in 20 individual samples with the lowest OFC 
(below -4 SD). In the 10 individuals with macrocephaly, direct sequencing for PTEN 
gene was performed. 
1.2.4. Ethical consideration 
Informed consents were obtained from parents or legal representatives, and the 
study has been approved by the Ethical Board of the University of Diponegoro/Kariadi 
Hospital, Semarang, Indonesia. Abnormal test results were discussed with parents or 
legal representatives genetic counselling was provided. 
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1.3. Outline of the thesis 
At the onset of the work described in this thesis, only a partial genetic 
diagnostic work-up of the ID population in Indonesia was performed (Hussein, 1998; 
Faradz et al., 1999). The first screening study for ID in a large cohort of Indonesian 
individuals was carried out using conventional cytogenetics and FMR1 gene analysis 
with the main focus on males (Hussein, 1998; Faradz et al., 1999). Since then, genetic 
diagnostic work-up studies were performed only in relatively small ID populations 
focusing on FXS and chromosomal abnormalities. In addition, genetic testing is not a 
routine diagnostic tool for ID patients in Indonesia although some basic techniques 
such as cytogenetic analysis and PCR-based FMR-1 gene analysis are available. 
Furthermore, due to the perception that the main health problems of childhood 
morbidity and mortality are socioeconomic and environmental such as malnutrition and 
infection, genetic disorders have not received much attention from the government and 
medical practitioners. Therefore, this study aimed at recording aetiological diagnosis of 
ID, performing phenotype-genotype correlation studies, and defining a diagnostic 
protocol for ID which is applicable in the Indonesian context. Furthermore, it was 
intended to strengthen the position of medical genetics in Indonesia for the benefit of 
patient care, teaching and research and to enhance genetic awareness of the 
Indonesian medical profession and the public at large, by providing evidence of an 
important genetic contribution into the causation of ID. In addition, the identification of 
the aetiology of ID is of major importance for patients and their families, since it allows 
reliable genetic counselling to their families and a better clinical management of the 
patients. 
The general goal of the research described in this thesis was to obtain a better 
understanding of the genetic aetiology of ID in Indonesia by aiming at the following 
objectives: 
I. Determination of the frequency of cytogenetic abnormalities in Indonesian 
ID population. 
II. Determination of the frequency of FXS in Indonesian ID population. 
III. Determination of the frequency of subtelomeric deletions and duplications 
in Indonesian ID population. 
IV. Determination of the aetiology in subgroups of ID individuals suspected of 
having a specific syndrome. 
V. The establishment of diagnostic protocol for the Indonesian setting  
Using conventional cytogenetic analysis with confirmation by some stand-
alone molecular tests, we determined the frequency of cytogenetic abnormalities in a 
cohort of Indonesian individuals with ID (Chapter 2). The molecular identification of 
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FXS syndrome in Indonesian ID population allows tracking of individual’s relatives with 
the same disorder. We determined the frequency of FXS in males and females, and 
documented the relatives with similar disorder (Chapter 3). Using MLPA, we 
determined the frequency of subtelomeric deletions and duplications in a cohort of 
Indonesian individuals with ID, who had a normal karyotype and who were FXS 
negative (Chapter 4). A subset of ID individuals was suspected of having a specific 
syndrome, and molecular testing of the genetic defect involved in these syndromes was 
carried out in these patients. Patients suspected for Prader-Willi syndrome and 
Angelman syndrome were tested by MLPA analysis, two individuals highly suspicious 
of Angelman syndrome were tested for mutations in the UBE3A gene. Other 
syndromes tested are Lujan-Fryns syndrome (UPF3B and MED12), Cowden syndrome 
(PTEN), Pitt-Hopkins syndrome (TCF4) and Mowat-Wilson syndrome (ZEB2). In larger 
patient cohorts molecular screening of some genes associated with ID and epilepsy 
(SCN1A, LGI1, ARX, STXBP1 and LGI1), macrocephaly (PTEN) and microcephaly 
(ASPM, WDR62, MCPH1, CDK5RAP2, CENPJ, STIL), were tested. Almost all tests for 
these specific syndromes turned out to be negative. The positive case with Mowat-
Wilson syndrome, and the results of testing the microcephaly genes are described in 
chapter 5. In chapter 6, the implication of this work including the establishment of a 
diagnostic protocol for the Indonesian setting is discussed. In addition, a general 
discussion and future directions towards a better genetic diagnostic workup in 
Indonesia are also provided.  
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Abstract  
Genetic factors play a significant role in the etiology of intellectual disability (ID). The 
goal of this study was to identify microscopically visible chromosomal abnormalities in 
an Indonesian ID population and to determine their frequency, pattern and clinical 
features. A total of 527 intellectually disabled individuals from special schools and 
institutions in 4 different areas on Java Island, Indonesia, were screened for 
cytogenetic abnormalities. Additional analyses were carried out for verification or further 
characterization by using fluorescence in situ hybridization, multiplex ligation-
dependent probe amplification or analysis of the FMR1 promoter CGG(n) repeat. Of the 
527 individuals with ID, chromosomal abnormalities were found in 87 cases (16.5%). 
Trisomy 21 was the major chromosomal abnormality, identified in 74 patients (14%). 
Other chromosome abnormalities included 8 X-chromosomal and 5 autosomal 
aberrations. Details on chromosome aberrations and confirmation analyses are 
discussed. This study shows that chromosomal abnormalities are an important cause of 
ID in Indonesia. Cytogenetic analysis is important for an adequate diagnosis in patients 
and subsequent genetic counseling for their families, especially in developing countries 
with limited facilities such as Indonesia. 
 
Keywords: Cytogenetic abnormalities, Indonesia, intellectual disability 
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Introduction 
Intellectual disability (ID) is a major health problem worldwide. In addition to 
health problems individuals with ID need more educational and psychological attention. 
Moreover, most of those with severe ID require lifelong nursing, guidance and 
surveillance (Schalock et al., 2007). 
Known causes of ID are biochemical/metabolic defects, chromosomal 
abnormalities, mutations in single genes (Mendelian disorders and mitochondrial 
disorders), multi-factorial disorders with a polygenic predisposition and non-genetic 
causes (Chiurazzi and Oostra, 2000; van Karnebeek et al., 2005). Pathogenic 
chromosomal abnormalities are the most common genetic cause of ID (Stevenson et 
al., 2003; Mefford, 2009). Microscopically visible numerical and structural abnormalities 
account for 7 – 56% of cases depending on techniques used and patient selection 
(Fryns et al., 1986; Dereymaeker et al., 1988; Fryns et al., 1990; Felix et al., 1998; 
Santos et al., 2000; Shiue et al., 2004; Dayakar et al., 2010). Down syndrome is the 
most common chromosomal abnormality causing ID which can be easily detected by 
using routine chromosomal analysis (Tolmie and MacFayden, 2007). 
To date, there are few data on incidence and cause of ID in Indonesia, even 
though, approximately 66,500 pupils have been registered in special schools for 
intellectually disabled individuals (Kemendiknas, 2010). This number, however, is far 
lower than the total number of ID individuals in Indonesia. 
Cytogenetic analysis has not been recognized as a routine diagnostic tool for 
ID individuals in Indonesia, although the technique is available. Furthermore, genetic 
disorders have not received much attention from the government and medical 
practitioners, partly because the main health problems for childhood morbidity and 
mortality are socioeconomic and environmental such as malnutrition and infection. 
Previous studies in the Indonesian ID population primarily focused on the 
Fragile X syndrome (Hussein, 1998; Faradz et al., 1999). Therefore, this study aimed to 
determine the prevalence and pattern of microscopically visible chromosomal 
abnormalities and the clinical features of positive cases in ID individuals in Indonesia. 
 
Materials and methods 
Patient selection and setting  
A total of 527 participants (329 males and 198 females) were included in the 
study, their ages ranged from 6 to 25 years and they were from four different places on 
Java Island, Indonesia (Semarang, Temanggung, Yogyakarta, and Bandung). Of the 
527 patients, 156 were institutionalized and 371 attended special schools. The majority 
of the individuals (n=345) appeared to be mildly intellectually disabled, 161 were 
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moderately disabled, and 21 were severely disabled, respectively (Table 1). Informed 
consent was obtained from the parents or legal representatives and the study was 
approved by the Ethical Board of the University of Diponegoro/Kariadi Hospital 
Semarang, Indonesia. All participants underwent a standardized clinical examination 
before blood was drawn. This examination comprised physical measurements and 
dysmorphological assessment.  
Table 1. Characteristics of the study population 
Characteristic  Participants (n) 
Sex   
   Male  329  
   Female  198  
Area/city   
   Semarang  327  
   Temanggung  134  
   Yogyakarta  11  
   Bandung  55  
School type   
   Institution  156  
   Special school  371  
ID severity   
   Mild  345  
   Moderate  161  
   Severe  21  
ID, intellectual disability.  
 
Peripheral blood samples were collected from December 2006 to November 
2008, and cytogenetic analysis was performed on all 527 samples. Structural 
abnormalities were confirmed by multiplex ligation-dependent probe amplification 
(MLPA) or fluorescence in-situ hybridization (FISH). Southern blot analysis was carried 
out to confirm the presence of cytogenetically visible fragile sites on the X 
chromosome. 
Chromosome cultures and preparations were carried out as described 
elsewhere (Blennow, 2005). One hundred metaphases were screened for fragile sites 
on each sample. Subsequently, chromosome analysis was performed using G-banding 
technique on the level of 400 – 600 bands. At least 20 metaphases were scored for 
each patient and karyotyped. If a mosaicism was suspected, 50 – 100 cells were 
counted. 
 FISH analysis was performed using commercially available probes (Vysis, Inc., 
Downers Grove, Illinois, USA) according to standard protocols as previously described 
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(de Bruijn et al., 2001). Genomic DNA of each patient was isolated using the salting out 
method (Miller et al., 1988). MLPA analysis was performed as described elsewhere 
(Schouten et al., 2002; Koolen et al., 2004). Several probe-kits from MRC-Holland, 
Amsterdam, The Netherlands, were used in these experiments: SALSA P036D and 
SALSA P070 (probes specifically designed for subtelomeric chromosomal imbalances), 
SALSA P096 (probes for several ID syndromes), and SALSA P028 (methylation 
specific probes for chromosome 15).  
Southern blot analysis of the FMR1 CGG(n) repeat was performed as 
described previously (Oostra et al., 1993; Smits et al., 1994). 
 
Results 
Chromosomal abnormalities were found in 87 (16.5%) of the 527 intellectually 
disabled individuals, trisomy 21 was the major chromosomal abnormality, occurring in 
74 cases (14%). The latter cases consisted of  71 with a full blown classical trisomy 21 
(43 males and 28 females), 2 with a mosaicism of trisomy 21 [47,XX,+21(73)/46,XX(27) 
and 47,XY+21(65)/46,XY(35)] respectively (Table 2), and 1 with a Robertsonian 
translocation (46,XX,der(14;21)(q10;q10),+21) (Table 3, Case 1). The latter patient’s 
mother’s karyotype was normal, and her father’s sample was not available. Therefore, 
we could not determine whether this translocation was de novo or inherited from her 
father.  
Table 2. Numerical chromosome aberrations detected in 527 intellectually 
disabled Indonesian individuals 
Chromosomal 
abnormality  Karyotype  Cases (n)  
Down syndrome  47,XX, + 21  28  
 47,XY, + 21  43  
 47,XX, + 21(73)/46,XX(27)  1  
 47,XY, + 21(65)/46,XY(35)  1  
Turner syndrome  45,X(10)/46,XX(90)  1  
Other X aneuploidy  47,XXX  1  
 
In 13 cases, chromosomal abnormalities other than Down syndrome were 
detected. Two participants had X-chromosomal aneuploidies (45,X(10)/46,XX(90) and  
47,XXX; Table 2). For both females the chromosomal aberration detected is not a 
satisfactory explanation for their moderate ID. The other 11 cases are structural 
chromosome aberrations (cases 2-12, Table 3). 
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Table 3. Structural chromosome aberrations detected in 527 intellectually 
disabled Indonesian individuals 
Case 
no.  Karyotype  
Molecular 
confirmation  Parents  
1  46,XX,der(14;21)(q10;q10), + 21  NT  Maternal karyotype normal;  
   paternal karyotype unavailable  
2  46,XX,del(18)(q21.3-qter)dn  FISH: Del 18qter  Normal karyotypes  
3  46,XY,der(4)t(4:8)(p16;p23)dn  FISH and MLPA: 
Del4pter/dup8pter  
Normal karyotypes  
4  46,XX,der(10)t(4:10)(p16;q26)  FISH and MLPA: 
Del10q/dup4p  
NT  
5  46,XX t(3;12)(p14.1;q21.2)  MLPA: Normal  NT  
6  47,XY,idic(15)(q13)  MLPA: Dup 15 
(maternal origin)  
NT  
7  46,XX,del(X)(q21-qter)  NT  NT  
8  46,XY,fra(X)(q27.3)  SB, full mutation  Mother is premutation carrier  
9  46,XX,fra(X)(q27.3)  SB, full mutation  Mother is premutation carrier  
10  46,XY,fra(X)(q27.3)  SB, full mutation  Mother is premutation carrier  
11  46,XY,fra(X)(q27.3)  SB, premutation–full 
mutation (mosaic)  
Mother is premutation carrier  
12  46,XY,fra(X)(q27.3)  SB, premutation–full 
mutation (mosaic)  
Mother is premutation carrier  
FISH, fluorescent in situ hybridization; MLPA, multiplex ligation-dependent probe amplification; NT, not 
tested; SB =Southern blot analysis. 
Apart from the t(14;21) case, autosomal structural abnormalities were found in 
5 cases (1.0%): 2 unbalanced translocations, 1 balanced translocation, 1 deletion, and 
1 isodicentric chromosome. No further confirmation test was performed on the Down 
syndrome cases, the cases with an X-chromosomal aneuploidy (Table 2) and a case 
with the large visible terminal Xq deletion (case 7). Five samples from 4 males and 1 
female patient were identified to have a fragile site at Xq27.3 (cases 8-12). Southern 
blot analysis confirmed the presence of a fully methylated expansion (>200 CGG 
repeats) in the promoter region of the FMR1 gene in each of the 5 cases. 
MLPA or FISH analysis was used to confirm the structural chromosomal 
abnormalities in cases with autosomal aberrations (cases 2-6). Whole chromosome 
paints of chromosome 18 confirmed a missing part of chromosome 18 in the sample of 
the patient with 46,XX,del(18)(q21.3qter)dn (case 2). Further analysis using an 18q 
telomere FISH probe detected only 1 signal from chromosome 18. Her parent's 
karyotypes were normal, confirming de novo occurrence. This patient had clinical 
features resembling those of previously described patients with a similar chromosomal 
aberration (Kimpen et al., 1991; Kline et al., 1993) (Figure 1). 
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Figure 1. Patients with a chromosomal abnormality 
 
(A) Case 2. (B) Case 3. (C) Case 4. (D) Case 5. (E) Case 6. (F) Case 7. 
 
In case 3, cytogenetic analysis revealed 46,XY,del(4)(p16). However, 
confirmation with MLPA analysis demonstrated not only a deletion of chromosome 
4pter but also a duplication of 8pter (SALSA MLPA kits P036D and P070, MRC-
Holland, Amsterdam, The Netherlands). Afterwards FISH was performed by using 
probes for the subtelomeric regions of chromosome 4p and 8p indeed only 1 signal for 
4pter and 3 signals for 8pter (1 of which was on the derivative chromosome 4) were 
detected. Both parents showed normal karyotypes, and carriership of a balanced 
translocation has been excluded. Therefore, the karyotype of the patient should be 
designated as: 46,XY,der(4)t(4:8)(p16;p23)dn. Further characterization was performed 
with MLPA analysis by using several probes from the Wolf-Hirschhorn Syndrome 
Critical Region (WHSCR) (SALSA MLPA kit P096). This analysis revealed a deletion of 
the entire WHSCR. The cytogenetic and molecular analyses confirmed the clinical 
diagnosis of Wolf-Hirschhorn syndrome (Figure 1). 
In case number 4 cytogenetic analysis revealed a karyotype of 
46,XX,add(10)(q26). However, MLPA demonstrated a deletion of chromosome 10qter 
and a duplication of 4pter. Subsequently, FISH was performed using probes for the 
subtelomeric regions of chromosome 10q and 4p. Only 1 signal for 10qter and 3 signals 
for 4pter (1 of which on the aberrant chromosome 10q) were detected. Consequently, 
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the karyotype of the patient should be designated as: 46,XX,der(10)t(4:10)(p16;q26). 
Unfortunately, this patient’s parents were unavailable for testing. Because  4pter 
duplications are reported in patients with and without ID and distinctive facial features 
(Gerard-Blanluet et al., 2004; Rodriguez et al., 2007), it is suggested that the 
phenotype in case 4 most likely is due to the deletion of 10qter. The clinical features of 
this patient are in concordance with the consistent phenotype of patients with a 
10q26.1qter deletion, as described by (de Vries et al., 2003) (Figure. 1). 
 In case 5 (Figure. 1), in which chromosome analysis revealed a 
46,XX,t(3;12)(p14.1;q21.2) karyotype, further confirmation using MLPA showed a 
normal result. It is therefore suggested that the aberration was a (cytogenetically) 
balanced translocation. Neither parent was unavailable for testing. In case 6 
cytogenetic analysis showed a 47,XY,idic(15)(q13). MLPA analysis of probes in the 
15q11.2-15q15.1 region (MRC Holland kit P028) showed 4 copies of the probes 
between BP1 and BP4 (including TUBGCP5 and TJP1), and 3 copies of the probes in 
the TRPM1, KLF13, and CHRNA7 genes (between BP4 and BP5) (Miller et al., 2009). 
The methylation specific analysis indicated that the marker was of maternal origin.  The 
patient’s parents were unavailable for testing. Clinical features were severe ID, epilepsy 
and very poor language expression, which are in fact the main features of idic (15) 
syndrome (Battaglia, 2008) (Figure. 1). 
Case 7 had a deletion of part of the long arm of one of her X chromosomes 
[46,X,del(X)(q21qter)]. She had mild ID and obvious dysmorphisms (Fig. 1). Females 
with a similar aberration have been reported to show mostly only mild Turner stigmata 
or subtle dysmorphisms, next to ovarian failure. ID, however, was not reported in these 
females (Graham et al., 2007), which makes it unlikely that the chromosomal aberration 
directly causes the ID in this patient and further investigations such as X inactivation 
studies are needed. 
Four males and 1 female expressed a fragile site on the X chromosome. 
Southern blot analysis confirmed that they all had fragile X syndrome. Three cases 
(patients 8, 9 and 10) had a full mutation of FMR1, and 2 (cases 11,12) showed a 
mosaicism (premutation and full mutation). 
After exclusion of  individuals with chromosomal aberrations other than Fragile-
X syndrome (82 patients for the whole population and 46  for the male population), the 
prevalence of Fragile-X syndrome in this study is 1.1% (5 of 445) among the whole 
study population and 1.4% (4 of 283)  in the male population. 
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Discussion 
 The overall frequency of microscopically visible chromosomal aberrations in 
this study was 16.5%. This is similar to the rate reported in other studies (13.3%-
17.6%) (Fryns et al., 1986; Dereymaeker et al., 1988; Fryns et al., 1990), although 
different frequencies were found in other studies: 7.9% (van Karnebeek et al., 2002), 
22.4% (Shiue et al., 2004), 28.6% (Santos et al., 2000), 34.2%  (Felix et al., 1998) and 
56% (Dayakar et al., 2010). These differences might be due to variations in inclusion 
criteria of patients. van Karnebeek and colleagues found a lower frequency of 
microscopically visible aberrations, possibly because the study was performed in a 
tertiary care centre (outpatient clinic) (van Karnebeek et al., 2002). Some studies 
generated higher frequencies than our study (Table 4) and this may have occured 
because more patients with moderate and severe or profound ID were included. These 
differences might also be due to pre-selection of cases without known non-
chromosomal causes of ID or multiple congenital anomalies, as was done by Dayakar 
et al., (2010). 
Table 4. Frequency of microscopically visible chromosomal aberrations in 
current study compared with previous studies 
 
Overall 
frequency 
Structural 
abnormalities 
Numeric 
abnormalities 
Down syndrome 
in patients  
Study (year)  with cytogenetic 
abnormalities  
van Karnebeek et al. (2002)  7.9 (21/266)  4.9 (13/266)  3.0 (8/266)  0 (0/21)  
Dereymaeker et al. (1988)  13.3 (21/158)  3.8 (6/158)  9.5 (15/158)  71.4 (15/21)  
Fryns et al. (1986)  15.0 (26/173)  2.3 (4/173)  12.7 (22/173)  84.6 (22/26)  
Current study  16.5 (87/527)  2.3 (12/527)  14.2 (75/527)  85.1 (74/87)  
Fryns et al. (1990)  17.6 (46/262)  1.2 (3/262)  16.4 (43/262)  93.4 (43/46)  
Shiue et al. (2004)  22.4 (94/419)  2.6 (11/419)  19.8 (83/419)  81.9 (77/94)  
Santos et al. (2000)  28.6 (28/98)  6.1 (6/98)  22.5 (22/98)  42.9 (12/28)  
Felix et al. (1998)  34.2 (69/202)  1.5 (3/202)  32.7 (66/202)  94.2 (65/69)  
Dayakar et al. (2010)  56 (56/100)  11 (11/100)  45 (45/100)  51.78 (29/56)  
Data are expressed as % (n/n). 
 The-male-to-female ratio in our study was 1.66:1 which is higher than in some 
previous publications (1.2:1 - 1.4:1) (Roeleveld et al., 1997; Partington et al., 2000; 
Macayran et al., 2006; Lin, 2009), but lower than in other studies, which reported a 
male to female ratio as high as 3:1 (Shin and il, 1999; Tang et al., 2008). The sex ratio 
differences might be explained by the differences in selection and case ascertainment 
(Roeleveld et al., 1997). Another ascertainment bias in our setting might be that parents 
seek assistance more frequently for boys than for girls, due to generally higher 
expectation for male children.  
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 Fourteen percent of the intellectually disabled individuals in this study had 
Down syndrome. This finding confirms that the syndrome is the most common 
chromosomal abnormality involved in ID. Severe cases, such as trisomy 13 and trisomy 
18 were not found in our study, most likely because these patients died before they 
reached school age. The prevalence of Down syndrome in our study is similar to that in 
previous studies conducted in the Indonesian population (12–14%) (Hussein, 1998). In 
addition, the prevalence of Down syndrome in our study resembled the frequency of 13 
– 15% reported in a white population (Matilainen et al., 1995; van Buggenhout et al., 
1999). We found a male-to-female ratio of 1.5:1 in Down syndrome cases, which 
reflects the male excess in our study population. The proportion of patients with Down 
syndrome among all male (43 of 329 [13%]) and all female (28 of 198 [14%]), 
participants, however, was similar, which corresponds to previous reports in this 
population (Hussein, 1998). 
 The prevalence for Fragile-X syndrome in this study was 1.1% (5 of 445) 
among the whole study population and 1.4% (4 of 283) in the male population. A 
previous study among intellectually disabled individuals in Indonesia that used 
molecular analysis, showed a  similar FXS prevalence of 1.9% (5 of 262) in the male 
population (Faradz et al., 1999). It is also similar to that reported in some studies of 
white populations (2-3%) (de Vries et al., 1997; Hecimovic et al., 2002; Biancalana et 
al., 2004). The prevalence could have been higher if molecular analysis had been 
performed in all 527 patient samples, because not all carriers of the FRAXA mutation 
express the fragile site on karyotyping (Pembrey et al., 2001). However, because of 
limited availability of molecular testing in Indonesia, cytogenetic studies for fragile-X are 
still a useful tool to detect fragile-X(A) and other fragile site abnormalities, including 
FRAXE, FRAXF and fragile sites in autosomes (Hussein, 1998).  
 Our study shows that cytogenetic analysis is still a powerful tool to detect 
genetic abnormalities in the ID population. The fact that cytogenetic analysis can now 
be performed in Indonesia should be considered by granting agents, such as 
government and non-profit organizations, so that they may financially support genetic 
studies in developing countries such as Indonesia. Furthermore, because common 
infectious diseases and nutritional problems are becoming less prevalent in Indonesia, 
diagnostic facilities for genetic diseases must receive a higher priority. Such efforts 
would extend genetic analysis to more diverse populations than normally studied 
(Bustamante et al., 2011).   
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Conclusions 
 Chromosomal abnormalities play an important causative role in ID in 
Indonesia. However, because cytogenetic analysis is still not commonly performed in 
intellectually disabled individuals in Indonesia, the implementation of this technique in a 
routine diagnostic setting will help to establish a genetic diagnosis in individuals with ID 
in the local setting, and will improve the possibilities for genetic counseling to the 
families. 
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Abstract 
Aim: To investigate the prevalence of Fragile X syndrome (FXS) in intellectually 
disabled male and female Indonesians.  
Methods: This research is an extension of a previously reported study on the 
identification of chromosomal aberrations in a large cohort of 527 Indonesians with 
intellectual disability (ID). In this previous study, 87 patients had a chromosomal 
abnormality, five of whom expressed fragile sites on Xq27.3. Since FXS cannot always 
be identified by cytogenetic analysis, molecular testing of the fragile X mental 
retardation 1 CGG repeat was performed in 440 samples. The testing was also 
conducted in the five previously identified samples to confirm the abnormality. In total, 
molecular study was conducted in 445 samples (162 females and 283 males). 
Results:  In the cohort of Indonesian ID population, the prevalence of FXS is 9/527 
(1.7%). The prevalence in males and females is 1.5% (5/329) and 2% (4/198), 
respectively. Segregation analysis in the families and X-inactivation studies were 
performed. We performed the first comprehensive genetic survey of a representative 
sample of male and female ID individuals from institutions and special schools in 
Indonesia. Our findings show that a comprehensive study of FXS can be performed in a 
developing country like Indonesia where diagnostic facilities are limited.  
Conclusion: The prevalence of FXS is equal in females and males in our study, which 
suggests that the prevalence of FXS in females could be underestimated.  
Key words: Fragile X syndrome (FXS); Intellectual Disability (ID); Fragile X Mental 
Retardation 1; CGG Repeat; Indonesia 
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Introduction 
Fragile X syndrome (FXS) is the most common form of inherited intellectual 
disability (ID), with an estimated prevalence of 1 in 4000-6000 males and 1 in 7000-10 
000 females (Crawford et al., 2001). Expansion of a CGG repeat in the 5' untranslated 
region of fragile X mental retardation 1 (FMR1) is the most frequent cause of FXS 
(Strom et al., 2007; Hill et al., 2010). When the expansion exceeds the number of 200 
repeats (full mutation), the promoter region becomes hypermethylated and the FMR1 
gene is silenced. This leads to deficiency of the FMR1 protein (FMRP) (Chiurazzi et al., 
2004). FXS is inherited as an X-linked dominant disease with variable expressivity and 
reduced penetrance in females. The level of ID in FXS males ranges from mild to 
profound, whilst females are usually less affected (Hagerman and Hagerman, 2002; 
Oostra and Willemsen, 2002).  
Several behavioral characteristics associated with FXS include autism 
spectrum disorders, poor eye contact, short attention span, hyperactivity, several 
stereotypic behaviors (hand flapping, hand biting, preservative speech, echolalia), 
tactile defensiveness and anxiety related to social contact (Hagerman et al., 1992; 
Symons et al., 2003; Kaufmann et al., 2004; Budimirovic et al., 2006). The classical 
facial phenotype of FXS includes a prominent forehead, a long, narrow face, a 
prominent jaw, and prominent ears. The palate is often highly arched. Macro-orchidism 
is reported in more than 80% of post-pubertal and adult males. Connective tissue 
abnormalities such as soft velvet-like skin, joint hypermobility, pes planus, congenital 
hip dislocation, scoliosis and clubfoot are also commonly observed (Hagerman and 
Hagerman, 2002; Hersh and Saul, 2011). 
Diagnostic analysis of FXS is mainly based on direct amplification of the CGG-
repeat using flanking primers and Southern blot analysis (Fu et al., 1991; Oostra et al., 
1993; Smits et al., 1994; Zhou et al., 2004; Strom et al., 2007; Hantash et al., 2010). 
Standard PCR testing allows amplification of alleles up to 120-150 CGGs. Although this 
method cannot reveal full mutations, it allows precise sizing of premutation alleles. On 
the contrary, Southern blot analysis allows sizing of full mutations but is unable to 
discriminate between large normal and small premutation alleles (Zhou et al., 2004). To 
overcome these problems, several diagnostic laboratories recently changed their 
procedure to PCR-based tests that can amplify repeat alleles up to full mutations and 
are able to distinguish between female samples homozygous for a normal allele or 
heterozygous for a normal and an expanded allele (e.g., tests by Abbott, IL, United 
States, and Asuragen Inc, Austin, United States). While these procedures are routinely 
performed in the Western world, they are not being used as standard diagnostic tools in 
Indonesia, mainly due to costs and lack of adequate health insurance coverage. 
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In a previous study, the prevalence of FXS in the male Indonesian population 
was determined to be 1.9% (5/262) (Faradz et al., 1999). However, diagnostic testing 
for FXS is not routinely performed and widely available in Indonesia. Therefore, we 
aimed to identify unrecognized FXS individuals and to determine the prevalence in both 
male and female individuals with ID. In view of the fact that genetic testing is still 
uncommon practice in Indonesia, the detection of new FXS cases gives insight in to the 
prevalence of FXS in Indonesia and should promote awareness of this disease among 
medical doctors and health professionals in Indonesia. For the families involved, 
establishing a diagnosis will be beneficial since genetic counseling and carrier testing 
can be provided.  
 
Materials and methods 
Selection and setting  
This research is an extension of a previously reported study on the 
identification of chromosomal aberrations in a large cohort of 527 Indonesian ID 
patients from several special schools and institutions in Java Island, Indonesia. In this 
previous study, 87 patients had a chromosomal abnormality, five of whom expressed 
fragile sites on Xq27.3 (Mundhofir et al., 2012). Since FXS cannot always be identified 
by cytogenetic analysis, molecular testing of the FMR1 CGG repeat was performed in 
440 samples. The testing was also conducted in five previously identified samples to 
confirm the abnormality. In total, molecular study was conducted in 445 samples (162 
females and 283 males). 
Genomic DNA of each patient was isolated using the salting out method as 
described elsewhere (Miller et al., 1988), with slight modification. The CGG repeat in 
the FMR1 promoter was amplified as described by Fu et al., (1991). Fragment length 
analysis was carried out on an ABI Prism 3730 DNA Analyzer (Life Technologies, 
Foster City, United States) and the Genemapper software (version 4.0, Apache) was 
used to determine the exact length of the CGG repeat. Southern blot analysis of the 
FMR1 CGG(n) repeat was performed as described previously. In families 5, 6 and 7 
(Figure 1), a more detailed analysis of the repeat length was performed using a three-
primer CGG repeat primed FMR1 PCR method (Asuragen Inc, Austin, USA), according 
to the manufacturer's protocol. The difference between the distribution of the full 
mutation allele in males and females was calculated using a χ2
A clinical reinvestigation was done in the positive cases and family members at 
risk of being a carrier were molecularly tested. X-chromosome inactivation (XCI) 
analyses were performed in all full mutation females in order to explain their 
phenotypes. Family members from all affected individuals were counseled and 
 test.  
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extended pedigrees were drawn. Thirty nine family members were available for 
molecular testing and clinical examination was only performed in family members with 
obvious signs of ID. The XCI pattern was studied in female samples with a full mutation 
(either clinically affected or unaffected) as described before (Spath et al., 2010).  
Results 
In a total of 445 (162 females and 283 males) molecularly tested individuals 
(607 alleles) 593 alleles are within the normal range (15-44 CGG repeats), 3 alleles in 
the intermediate range (45-55 CGG repeats), 2 alleles in the premutation range 
(between 55 and 200 CGG repeats) and 9 alleles in the full mutation range (> 200 CGG 
repeats) (classification according to the American College of Obstetricians and 
Gynecologists Committee Opinion No. 469). The 29 allele (n=245) was the most 
frequent allele in this population, followed by 28 CGG repeats (n=127) and 30 CGG 
repeats (n= 93).  
The five samples (4 males and 1 female) in which fragile sites were shown in 
previous chromosome analyses indeed showed a full mutation with Southern blot 
analysis, therefore confirming the diagnosis of FXS. Another four samples (1 male and 
3 females) were newly identified to have a full mutation. Two of the positive male 
samples showed a mosaic pattern of premutation to full mutation (Family 2/III:2 and 
Family 5/III:2, Table 1). A χ2 test revealed no statistically significant differences in the 
distribution of full mutation alleles between males and females (χ2 
Table 1. Fragile X mental retardation 1 gene analysis of index fragile X syndrome 
subjects 
= 0,184; df = 1; P = 
0.67). 
Patient  Sex  FMR1 gene analysis  
Family1/Ⅲ:3  Male  Full mutation  
Family 2/Ⅲ:2  Male  Mosaic premutation/full mutation  
Family 3/Ⅲ:2  Female  Full mutation  
Family 3/Ⅲ:9  Female  Full mutation  
Family 4/Ⅳ:3  Male  Full mutation  
Family 5/Ⅲ:2  Male  Mosaic premutation/ full mutation  
Family 6/Ⅲ:1  Male  Full mutation  
Family 7/Ⅲ:2  Female  Full mutation  
Family 7/Ⅲ:3  Female  Full mutation  
   FMR1: Fragile X mental retardation 1. 
 
Pedigree analysis of the nine FXS cases showed that two individuals were 
related to two other index cases in other families (first cousins in two different families) 
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(Family 3/III:2 and III:9; Family 7/III:2 and III:3, Table 1). Therefore, only seven families 
were identified in this study (Figure 1). Molecular testing of potential carriers in those 
families resulted in the identification of 17 samples with a premutation (11 females and 
6 males). In one of the 11 females (Family 6/III:3), the Southern blot result could not 
clearly distinguish between a large premutation or full mutation. More detailed analysis 
using repeat-primed PCR (Asuragen Inc., Austin, United States) revealed a 
premutation. Furthermore, another six full mutation cases were identified: five females 
(two mildly affected and three clinically unaffected) and one clinically affected male. 
Figure 1. Pedigrees of Fragile X syndrome families 
 
Besides the nine index cases (indicated by an arrow), six additional family members with a full mutation 
(five females, full black circle and one male, indicated by full black square) and 17 individuals [11 males; 
5 females (indicated by dotted circle)] with a premutation have been identified. The length of the CGG 
repeats is depicted below the pedigree number of each tested individual. The X-inactivation (XCI) of full 
expansion females is shown at the upper right of the pedigree symbol (+ for non-random XCI and - for 
random XCI). Asterisk at the upper right indicated a mosaic premutation to full mutation. 
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X-inactivation studies were performed in all nine females with a full mutation. 
Four females (two mildly affected and two unaffected) showed random patterns of 
inactivation (Table 2). Four out of five samples with non random patterns of inactivation 
[> 80:20, defined by Amos-Landgraf et al., (2006)] are from clinically affected females, 
while the 5th
Table 2. X chromosome inactivation pattern in all full mutation females 
 one is not affected. Southern blot analysis showed that in the unaffected 
female the normal allele was active and the expanded allele was inactive, whereas in 
the affected females the normal allele was inactive.  
Pedigree  XCI  Clinical features  
Family 3/Ⅲ:2  87/13 (non random)1  Affected  
Family 3/Ⅲ:9 96/4 (non random)1  Affected  
Family 7/Ⅲ:2 93/7 (non random)1  Affected  
Family 7/Ⅲ:3  82/18 (non random)1  Affected  
Family 1/Ⅲ:6  75/25 (random)  Affected (mild)  
Family 4/Ⅳ:1  74/26 (random)  Affected (mild)  
Family 3/Ⅲ:6  60/40 (random)  Not affected  
Family 4/Ⅲ:3  84/16 (non random)2  Not affected  
Family 5/Ⅱ:2  67/33 (random)  Not affected  
1The normal allele is inactive by X chromosome inactivation (XCI) and the expanded allele is active but 
methylated because of the expansion; 2
 
the normal allele is active and the expanded allele is not active. 
A summary of the most common features of the index patients and affected 
family members is shown in Table 3, for male and female individuals, respectively. 
Clinical pictures of index patients and affected family members are depicted in Figure 2. 
In male individuals, shy behavior (shy and timid behavior with a tendency towards 
social withdrawal) and social anxiety are the most frequent features (detected in all six 
males=100%), followed by large cupped ears, elongated face and joint laxity (detected 
in 83%). Four of post pubertal individuals had large testicular size (67%). Highly arched 
palate, scoliosis and flat feet were found in three patients (50%), whereas neurological 
problems (seizure, spasticity of the extremities and strabismus) were found in one 
patient. In females, shy behavior and social anxiety are the most frequent features 
(100%), whereas joint laxity and flat feet were found in five (83%). Four females 
showed large cupped ears, elongated face and high arched palate (67%). Scoliosis and 
strabismus were found in three and two individuals, respectively (50% and 33%). 
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Figure 2 Clinical pictures of patients with Fragile X syndrome. 
 
Fam: Family. 
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Discussion 
Few studies have been carried out to determine the contribution of FXS as a 
cause of ID in the Indonesian population (Faradz et al., 1999; Winarni et al., 2012). In 
this study, we performed a comprehensive genetic survey of a representative sample of 
male and female ID individuals from institutions and special schools. The prevalence of 
FXS found in this study was 1.7% (9/527); 1.5% (5/329) in the male population and 2% 
(4/198) in the female population. This prevalence of FXS is similar to that in other Asian 
populations (approximately 1%-3%) (Pang et al., 1999; Kwon et al., 2001; Pandey et 
al., 2002)  and is about the same as found in a previous study from Indonesia with a 
prevalence of 1.9% (5/262) in the male population (Faradz et al., 1999).  
The prevalence of FXS among females was estimated to be about half of that 
of males (Crawford et al., 2001). The actual distribution of full mutation alleles in the 
general population, however, is considered to be equal in both males and females 
(Hagerman, 2008), but due to the X-inactivation in females, they are usually less 
severely affected. With regards to the allele distribution of full mutation alone, this study 
yielded no statistically significant differences in males 1.5% (5/329) and females 2% 
(4/198). This finding is in line with the results of previous studies (Pang et al., 1999; 
Hagerman, 2008). The equal distribution of clinically affected females and males in the 
present study, however, was unexpected. In order to explain why most of the females 
with a full mutation in this study are clinically affected, the X inactivation status was 
determined. All female index patients (n=4) demonstrated a non random XCI, in which 
the normal unexpanded allele was preferentially inactivated. Although the XCI pattern 
in blood does not necessarily represent the pattern in the brain, the results in this family 
provide evidence for the fact that XCI patterns play a role in the development of 
cognitive disturbances in females with a full mutation. The results of the XCI assay in 
the five female family members with a full mutation are also in concordance with their 
clinical status: the two mildly affected females and two of the unaffected females 
showed random X-inactivation. The difference in intellectual abilities between these 
females might possibly be explained by a difference in the X-inactivation pattern in 
brain. One of the unaffected females showed non-random X-inactivation (Family 
4/III:3), but since the normal allele was preferentially active, this explains why she has a 
normal phenotype. This study clearly demonstrates why females with full mutation 
alleles can be affected or unaffected, depending on their XCI pattern, a feature that has 
been recognized before (Reiss et al., 1995; de Vries et al., 1996; Heine-Suner et al., 
2003; Migeon, 2006). The percentage of clinically affected females (due to non random 
X-inactivation) in the present study is considerably higher than what has been reported 
among the full mutation female population: 44% (4/9) in this study vs 24.1% (7/29) 
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reported by Reiss et al., (1995). Further studies on larger numbers of full mutation 
females have to be performed in order to confirm this high percentage of non-random 
X-inactivation in our female population.  
In family 5, the affected index male (III:2) showed a mosaic premutation to full 
mutation (71/>>). Segregation analysis using Southern blot in the family demonstrated 
that the mother was a carrier of a full mutation. In order to exclude the possible 
presence of a low amount of premutation alleles in the mother, an additional test using 
a repeat-primed PCR was performed. The analysis confirmed that the mother was a 
carrier of a normal allele (44 CGG repeats) and a full mutation allele (294 CGG 
repeats) without evidence of mosaic premutation allele. This indicates that the full 
mutation allele of the mother was transmitted to her son in reduced size. Although the 
molecular mechanisms responsible for the reduction of the CGG repeat in the FMR1 
gene are largely unclear, several other cases where full mutation carrier females had 
affected sons with a mosaic pattern, have been described (Malzac et al., 1996; 
Rousseau et al., 1991). One of the mechanisms explaining repeat contraction (but also 
expansion) is slipped strand mispairing (Chiurazzi et al., 1994; Tabolacci et al., 2008). 
Another explanation is that the contraction could be a postzygotic event due to somatic 
instability of the CGG repeat (Dobkin et al., 1996; Reyniers et al., 1999; Taylor et al., 
1999).  
Individuals who have a mosaic premutation to full mutation may have a milder 
phenotype compared to those with a full mutation (Cohen et al., 1996). Besides patient 
III:2 from family 5, patient III:2 from family 2 also showed a mosaic pattern on the 
Southern blot. Notably, one of the male family members with a normal intelligence was 
also identified to have a mosaicism of a premutation (81 CGG repeats) and a full 
mutation allele (Family 6/II:4). However, the full mutation allele was not visible on the 
Southern blot and was only detected after the repeat-primed PCR which was performed 
in order to better characterize the repeat number in his daughter. This may indicate that 
the fully expanded allele was present only in a small percentage of cells, explaining the 
normal phenotype.  
The most frequent clinical features found in both sexes in our population were 
shy behavior and social anxiety, large cupped ears, elongated face and joint laxity. 
These features were consistent with those described for FXS (Hagerman et al., 1992; 
Hagerman and Hagerman, 2002; Hersh and Saul, 2011).   
Cytogenetic testing to detect FXS is no longer considered to be sufficiently 
accurate because of its high false negative and false positive rates (Hersh and Saul, 
2011), the main difficulty being the detection of females with a full mutation (Jenkins et 
al., 1991; Sutherland et al., 1991). Indeed, in our study cytogenetic analysis only picked 
up five out of nine samples, most of which were males. Although cytogenetic diagnosis 
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is still useful and affordable to establish a FXS diagnosis in developing countries, this 
study emphasizes the significance of molecular screening. Moreover, despite the fact 
that the PCR-based test is available at the Center for Biomedical Research (CEBIOR) 
at Diponegoro University, testing for FXS in the ID population in Indonesia is not 
routinely performed and CEBIOR is the only laboratory to perform FXS diagnosis in 
Indonesia. It is recognized that FXS is an inherited disease; however, establishing a 
diagnosis and providing possibilities for genetic counseling and carrier testing is not 
seen as useful in Indonesia. Due to its high costs and limited accessibility, prenatal 
diagnosis is only available to a minority of the population. Even though termination of 
pregnancy is legal when based on a medical emergency, e.g. genetic diseases 
(Republic Indonesia Laws No. 36 / 2009), in practice it still is a very complex procedure. 
Also, other options such as preimplantation genetic diagnosis are financially and 
culturally complex. Still, as common infectious diseases and nutritional problems are 
becoming less prevalent in Indonesia, diagnostic facilities for inherited diseases such 
as FXS need to get a higher priority. In addition, medical personnel and stake holders 
at the Ministry of Health should be continuously informed about the problem of genetic 
diseases and its management.  
FXS testing is a common diagnostic procedure performed in all non-
microcephalic males with ID of unknown origin in Western countries (Ropers and 
Hamel, 2005). However, routine FXS testing in females with ID of unknown origin is 
said not to be warranted unless there are other indicators (e.g., a positive family 
history) (van Karnebeek et al., 2005). On the other hand, the American College of 
Medical Genetics strongly recommends fragile X testing to be considered in both 
genders with unexplained ID, especially in the presence of any physical or behavioral 
characteristics of FXS, a positive family history and relatives with undiagnosed ID 
(Sherman et al., 2005). Our findings support the notion to broaden FXS testing to 
include females, in view of the fact that the prevalence of FXS in females could be 
higher than thought up to now.  
 
Acknowledgments 
We thank all participants and their families for their contribution. Thanks to Dr. 
Alejandro Arias-Vasquez for statistical analysis. We also thank laboratory staff at the 
Department of Human Genetics, RUNMC, Nijmegen, The Netherlands and CEBIOR, 
FMDU, Semarang Indonesia; in particular Erwin Khüny, Jelmer Bokhorst, Wiwik Lestari, 
Lusi Suwarsi, Rita Indriati, Dwi Kustiani and Alfi Afadiyanti.  
 
Fragile-X syndrome in Indonesian ID population 
 
85 
 
Comments 
Background 
Fragile X syndrome (FXS) is the most common form of inherited intellectual 
disability (ID). Expansion of a CGG repeat in the 5’ untranslated region of fragile X 
mental retardation 1 (FMR1) gene is the most frequent cause of FXS. 
Research frontiers 
Diagnostic analysis of FXS is mainly based on direct amplification of the CGG 
repeat using flanking primers and Southern blot analysis. While these procedures are 
routinely performed in the Western world, they are not being used as standard 
diagnostic tools in Indonesia, mainly due to costs and the lack of adequate health 
insurance coverage. 
Innovations and breakthroughs 
In the previous study, the prevalence of FXS in the male Indonesian population 
was determined; however, diagnostic testing for FXS is not routinely performed and not 
widely available in Indonesia. Therefore, the authors aimed at identifying unrecognized 
FXS individuals and determining the prevalence in both male and female individuals 
with ID. They performed the first comprehensive genetic survey of a representative 
sample of male and female ID individuals from institutions and special schools in 
Indonesia. 
Applications 
Their findings show that a comprehensive study of FXS can be performed in a 
developing country like Indonesia where diagnostic facilities are limited. Moreover, their 
findings support the notion to broaden FXS testing to include females, in view of the 
fact that the prevalence of FXS in females could be higher than thought up to now. 
Terminology 
FXS is the most common inherited cause of ID. The spectrum of ID ranges 
from mild to severe, while physical features can include an elongated face, large and 
prominent ears, larger testes/macroorchidism (in males), behavioral characteristics 
such as stereotypic movements, and social anxiety. FXS is caused by mutations in the 
FMR1-gene. FMR1 is a gene in humans which encodes a protein called fragile X 
mental retardation protein. This protein is important for normal cognitive development. 
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Peer review 
This is a good descriptive study in which the authors investigate the 
prevalence of FXS in intellectually disabled male and female Indonesians. The results 
are interesting and suggest that the prevalence of FXS in females could be 
underestimated. 
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Abstract 
Context: Unbalanced subtelomeric chromosomal rearrangements are often associated 
with intellectual disability (ID) and malformation syndromes. The prevalence of such 
rearrangements has been reported to be 5-9% in ID populations.  
Aims: To study the prevalence of subtelomeric rearrangements in the Indonesian ID 
population. 
Methods and Material: We tested 436 subjects with unexplained ID using multiplex 
ligation dependent probe amplification (MLPA) using specific designed sets of probes 
to detect human subtelomeric chromosomal imbalances (SALSA P070 and P036D). If 
necessary, abnormal findings were confirmed by other MLPA probe kits, fluorescent in 
situ hybridization (FISH) or SNP array.  
Results: A subtelomeric aberration was identified in 3.7% of patients (16/436). Details 
on subtelomeric aberrations and confirmation analyses are discussed.  
Conclusions: This is the first study describing the presence of subtelomeric 
rearrangements in individuals with ID in Indonesia. Furthermore it shows that also in 
Indonesia such abnormalities are an important cause of ID and that in developing 
countries with limited diagnostic services such as Indonesia, it is important and feasible 
to uncover the genetic aetiology in a significant number of cases with ID. 
Key-words: Intellectual disability (ID), subtelomeric rearrangements, multiplex ligation-
dependent probe amplification (MLPA), Indonesia. 
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Introduction 
Genetic causes of intellectual disability (ID) comprise (sub)microscopically 
chromosome abnormalities and monogenic diseases (Ropers, 2010). Microscopically 
visible numerical and structural abnormalities are the most common cause of ID. In a 
large meta-analysis review, a median rate of 9.5% was described (van Karnebeek et 
al., 2005). Apart from these microscopically visible chromosomal abnormalities, there 
are submicroscopic abnormalities that cannot be detected by conventional karyotyping. 
Abnormalities in the most distal ends of chromosomes, which harbour the highest gene 
concentrations in the human genome (Rudd, 2012), are difficult to identify on routine 
chromosome analysis, while they represent an important genetic cause of idiopathic ID. 
Therefore, testing for such rearrangements has turned out to be an important clinical 
evaluation step in the etiological diagnosis of unexplained ID cases (de Vries et al., 
2003). In several studies, subtelomeric rearrangements were found to be associated 
with moderate to severe phenotypic abnormalities and turned out to be a significant 
cause of ID, with an estimated prevalence of 5-9% of cases in various populations (Wu 
et al., 2010; Christofolini et al., 2010; Jehee et al., 2011). To date, however, there is no 
data about the prevalence of subtelomeric rearrangements in Indonesia.  
In a large number of Indonesian ID patients, the cause of ID could be 
established by conventional karyotyping or molecular testing for Fragile X syndrome 
(FXS), but the majority of cases still remained unexplained (Mundhofir et al., 2012a). 
Therefore, this study aimed at determining the prevalence of subtelomeric 
rearrangements and the clinical features in these ID individuals in Indonesia. 
Methods 
This research is an extension of previously reported studies on the 
identification of genetic causes of ID in Indonesia, where chromosomal aberrations and 
FXS were investigated in a large cohort of 527 Indonesian ID individuals from several 
special schools and institutions in Java Island, Indonesia. These previous studies 
revealed chromosomal abnormalities in 82 individuals and FXS in 9 individuals 
(Mundhofir et al., 2012a; Mundhofir et al., 2012b). In the present study, molecular 
testing of subtelomeric deletions and duplications was performed in the 436 as yet 
unresolved patients (278 males and 158 females). Informed consent was obtained from 
the parents or legal representatives and the study has been approved by the Ethical 
Board of our institute. All subjects underwent a standardized clinical examination 
including physical measurements and dysmorphological assessment. 
DNA was isolated from peripheral blood using the salting out extraction 
procedure as described elsewhere (Miller et al., 1988). MLPA analysis was performed 
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as described previously (Schouten et al., 2002). Two probe-kits for subtelomeric 
chromosomal imbalances were used in these experiments: SALSA P070 and SALSA 
P036D MRC-Holland, Amsterdam, The Netherlands (http://www.mrc-holland.com). 
Each subtelomeric rearrangement was identified by at least one additional MLPA 
analysis using the SALSA P070 as the first level screening. Afterwards, SALSA P036D 
was utilized for confirmation of the aberration detected with the P070 kit. 
Rearrangements in specific regions were verified with SALSA kit P028, P023B, P340A 
or P096. The details of regions detected by each kit are available at 
http://www.mlpa.com. Amplification products were identified and quantified by capillary 
electrophoresis on an ABI 3730 genetic analyzer (Applied Biosystems, Foster City, CA, 
USA) using GeneMapper Software vs. 3.7 (Apache Software). Statistical analyses were 
carried out using Microsoft Excel spreadsheets as described before (Koolen et al., 
2004). Results were considered abnormal when the relative peak height ratio was 
below 0.70 or above 1.30.  
When a deletion or duplication was detected in both MLPA kits, parents were 
tested for de novo occurrence. When parental DNA was not available, additional 
methodologies were performed for confirmation of the presence of the detected 
deletion or duplication. Fluorescence in situ hybridization (FISH) analysis was 
performed using commercially available probes (Vysis, Inc., Downers Grove, Illinois, 
USA) according to the manufacturer’s recommendations. SNP array analyses were 
performed using the Affymetrix NspI 250K SNP array platform (www.affymetrix.com). 
Copy number estimates were determined using the Copy Number Analyzer for 
Affymetrix Genechip Mapping (CNAG) software package version 2 (Nannya et al., 
2005). The clinical data of all patients were reviewed and compared to other cases with 
a comparable aberration, described in the literature.  
Results 
The initial screening with the SALSA P070 probe kit showed a subtelomeric 
deletion and/or duplication in 23 of the 436 ID individuals (Table 1). In 20 of these 
samples the presence of the aberration could be confirmed by the SALSA P036D kit 
(cases 1-20, Table 1), while in the three remaining cases this was not possible and they 
were considered to be either artefacts or non-causative variants. Parental testing was 
possible in eight of the 20 cases (cases 1-8) and revealed a de novo occurrence of the 
subtelomeric imbalances in six cases (cases 1-6). These six aberrations were, 
therefore, considered to be pathogenic (Table 1 and 2). The phenotypes of cases 1 and 
2 share many similarities with known cases with  monosomy 18pter (Brenk et al., 2007) 
or a subtelomeric duplication of 9p24 (Ruiter et al., 2007) respectively. In cases 3, 4, 
and 5, a subtelomeric deletion appeared to be coexistent with a subtelomeric 
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duplication, which implicates the presence of a cryptic unbalanced translocation. The 
phenotype of case 3 was comparable to  reported cases with either a 4p duplication 
(Brenk et al., 2007) or an 18p deletion (Cyr et al., 2011). Therefore, either dup 4pter or 
deletion 18pter (or both) could be contributing to the phenotype in the case 3. In case 4, 
the phenotype is most likely due to the deletion of 10pter, because of the phenotypic 
overlap with previously reported cases with a deletion of 10p15 (Lindstrand et al., 
2010). The dysmorphic features of this case do not match the clinical description of 
another individual with a duplication of 9pter (Ruiter et al., 2007). In case 5, the 
9pter/qter deletion/duplication is considered to be causative. The clinical details have 
been reported elsewhere (Mundhofir et al., 2012c). In case 6, a de novo deletion of the 
X/Yqter pseudo autosomal region 2 (PAR2) was detected, which was previously also 
described in phenotypically normal individuals (DGV; http://www.tcag.ca/). Therefore, 
we performed an additional SNP array analysis to enable a fairly precise determination 
of the size of the deletion and link it to the severity of the clinical features. To our 
surprise, this revealed a 2 Mb deletion on chromosome 22q11 that has previously been 
described in patients with a similar phenotype (Repetto et al., 2009). We therefore 
conclude that the phenotype of case 6 is not due to the de novo X/Yqter deletion but 
due to the 22q11 deletion. 
In two cases (case 7 and 8) parental testing showed that the aberration was 
inherited from an unaffected parent. These aberrations were therefore considered to be 
familial variants that do not contribute to the phenotype in case 7 and 8. When parental 
samples were not available, we tried to confirm the presence of the detected 
subtelomeric aberration using additional methodologies (Table 1). The deletion of the 
entire Wolf-Hirschhorn critical region (WHSCR) in 4pter in case 9 was confirmed by 
MLPA with the SALSA P096 probe kit. Also the clinical features of this patient were 
consistent with Wolf-Hirschhorn syndrome. In case 10, two duplicated regions of 
chromosome 22 were identified, one in the 22q11.2 region (next to the centromere) and 
the other in the 22q13.3 region (telomere end of q arm of chromosome 22). The SALSA 
P023B probe kit was used to confirm these duplicated regions. Two duplications in one 
arm of the chromosome suggested a complex recombination. However, such 
recombination could not be identified in the routine analysis and warranted further 
characterization. Confirmatory analysis using SNP array showed that both duplications 
actually consisted of 2.6 Mb in 22q11.2 and 1.8 Mb in 22q13.33. Since 
microduplications of both 22q11.2 and 22q13.3 have been associated with highly 
variable phenotypic features (Feenstra et al., 2006; Rochebrochard et al., 2006),  we 
suggest that in case 10 both duplications contribute to the phenotype. 
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In cases 11 and 12, a subtelomeric deletion of 9pter was identified. Case 11 
showed a milder phenotype than previously reported cases (Hauge et al., 2008; 
Swinkels et al., 2008). In order to see if the deletion in case 11 was smaller than the 
deletions reported before, SNP array analysis was performed. The deletion appeared to 
be 11.8 Mb in size and it does not exceed the critical region of 9p syndrome (Hauge et 
al., 2008; Swinkels et al., 2008) this, therefore, explained the mild phenotype. In case 
12, however, the patient showed some similarities to the reported cases (Hauge et al., 
2008). Therefore, it is suggested that 9pter deletion in case 12 is causative and array 
analysis to determine the actual size of the deletion was unnecessary. 
In case 13, a microduplication of 15q11 was identified. MLPA analysis of 
probes in the 15q11.2-15q15.1 region (MRC Holland kit P028) showed a duplication of 
the probes between Breakpoint 1 and Breakpoint 3 (including TUBGCP5 and APBA2). 
The methylation specific analysis indicated that the interstitial duplication was of 
maternal origin. It is suggested, that the duplication explains mild ID and minor 
dysmorphic features in case 13, since duplications of 15q11 are associated with a 
highly variable phenotype (Bolton et al., 2001). 
In cases 14-20, parental testing and additional testing were not performed.  
This was due to the fact that in some cases, materials for additional testing were 
unavailable. Another reason was that the clinical features of the patient showed some 
similarities to the reported cases; therefore, additional testing was considered 
unnecessary. In case 14, a subtelomeric deletion of 2qter was identified. This patient 
showed shortening of the metacarpal bones which occurs in the majority of 2q37 
patients (Felder et al., 2009). It is suggested, therefore, that the deletion in this case is 
causative. In case 15, a subtelomeric deletion of Xpter and a subtelomeric duplication 
of 11pter were identified. The presence of both a deletion and a duplication suggests 
an unbalanced translocation.  The Xpter probes in the P070 and P036D MLPA kits are 
both located within the SHOX gene. Deletions of this gene are associated with Leri-
Weill Dyschondrosteosis (LWD) and idiopathic short stature (ISS) (Barroso et al., 2010; 
Hirschfeldova et al., 2012). A duplication of 11pter has been reported in a case of 
Silver-Russell syndrome (Eggermann et al., 2010). Therefore, both the dup 11pter and 
the deletion Xpter could be contributing to the short stature of this individual's 
phenotype.  
In case 16, the subtelomeric deletion of 12pter accompanied by a subtelomeric 
duplication of 12qter suggests that the recombinant chromosome resulted from a 
pericentric inversion in one of the parents. Unfortunately, his parents were unavailable 
to test. Lagier-Tourenne et al. (2004) reported two cases of microscopically visible 
recombinant chromosome 12 and reviewed all previously reported cases as well as 
cases with pure cytogenetic deletion of 12pter and duplication of 12qter. Compared to 
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these previously reported cases with larger abnormalities, our patient showed a milder 
phenotype such as minor facial dysmorphisms and mild ID (Table 2). It is suggested 
that the terminal duplication/deletion of chromosome 12 in this patient was smaller than 
previously reported and could contribute to the phenotype. 
In case 17, a subtelomeric deletion of 8pter was identified. He showed mild ID 
with minor facial dysmorphisms. A subtelomeric 8pter deletion is rare, and only few 
cases have been reported (de Vries et al., 2003). Wu et al., (2010) reported a patient 
with a very small deletion in terminal 8pter with ID, microcephaly and minor facial 
dysmorphisms. We therefore conclude that the clinical features of case 17 are most 
likely due to the deletion of 8pter. 
In case 18, a duplication of the probes in the SHOX gene in the pseudo-
autosomal region 1 (PAR1) Xpter/Ypter was identified. SHOX duplications limited to 
PAR1 appear to be rare, and the associated phenotype is highly variable (Thomas et 
al., 2009; Hirschfeldova et al., 2011). SHOX gene defects, either a deletion or 
duplication, were associated with LWD and ISS. It has to be noted, however, that the 
effect of a duplication is ambiguous (Hirschfeldova et al., 2012).  Consequently,  the 
clinical features associated with such duplication were likely to be under-ascertained 
(Hirschfeldova et al., 2011).  We are uncertain, therefore, whether the duplication of this 
gene contributed to the clinical phenotype or not.  
In cases 19 and 20, a subtelomeric duplication of 16qter was identified. A 
16qter submicroscopic microduplication is rarely reported. Ravnan et al., (2006) 
reported five cases with a duplication 16qter in which the duplicated signal was 
adjacent to the 18p subtelomere probe signal. In two cases the recombination 
appeared to be inherited from unaffected parents, and these were considered to be 
variants. Therefore, in the other three cases the recombination was also regarded to be 
a variant although parental samples were not available (Ravnan et al., 2006). It cannot 
be ruled out, however, that the duplication in cases 19 and 20 is contributing to their 
phenotype, since 16qter is a gene-rich region. More than ten genes are present in the 
~500 kb proximal to 16qter. Some of these (NULP1, TUBB3, and AFG3L1) are 
expressed in the brain (Zou et al., 2007), and it is possible that overexpression of these 
genes contributes to ID.  
Discussion 
This is the first study identifying subtelomeric chromosomal aberrations in 
Indonesian ID individuals. Overall, subtelomeric copy number rearrangements were 
established in 20 samples, explaining the phenotype of 16 cases. Therefore, a 
detection rate of 3.7 % (16/436) was obtained, of which 31% (5/16) was found to have 
a complex rearrangement/unbalanced translocation, 44% (7/16) had a simple deletion 
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and 25% (4/16) had a simple duplication. In addition, the subtelomeric rearrangements 
contributed as genetic cause of ID in 3% (16/527) of cases in the whole cohort. The 
deletions, including the complex rearrangements, involved nine different subtelomeric 
regions (2q, 4p, 8p, 9p, 10p, 12p, 18p, X/Yp, X/Yq); and duplications, including complex 
rearrangements, involved eight subtelomeric regions (4p, 9p, 9q, 11p, 12q, 15q11, 22p, 
X/Yp).  
The detection rate of chromosomal subtelomeric rearrangements  in this study 
is 3.7 % (16/436) which  is well within the range of 2.5% previously reported by Ravnan 
et al., (2006) and 4.4% as reported by van Karnebeek et al., (2005). Five individuals 
(5/16; 31%) are suggested to have an unbalanced translocation that was not detected 
by routine cytogenetic analysis. In two of these the translocation was shown to be de 
novo (case 3 and 4); in two individuals, parental samples were unavailable (case 15 
and 16); and inherited translocation was demonstrated in one case (case 5). The 
prevalence of these cryptic imbalances in our ID population is in the range of a previous 
study conducted by Wu et. al., (2010), who reported such rearrangements in 21.7% 
(5/23) and the study of Jehee et al., (2011) which reported such rearrangements in 
42.1% (8/19) (Wu et al., 2010; Jehee et al., 2011). The considerably high rate of 
unbalanced translocations observed in this study might be explained by the fact that we 
did not use high-resolution banding, which could have detected most ‘cryptic’ 
subtelomeric anomalies (Mundhofir et al., 2012a).  
Although the MLPA method is capable of revealing subtelomeric 
rearrangements, the clinical significance of each rearrangement should be interpreted 
carefully, particularly for cases in which the clinical features are different from 
previously reported cases. In case 6, for example, the de novo subtelomeric X/Yqter 
deletion could not explain the clinical features when compared to the previously 
reported cases (Parvari et al., 1999; Ravnan et al., 2006). Furthermore, in the DGV it is 
reported that rearrangements in this region can be detected in phenotypically normal 
individuals as well. Subsequent SNP array in this patient identified another abnormality 
which explained his clinical phenotype.  
To conclude, this is the first large-scale study of the detection of 
submicroscopic subtelomeric aberrations in Indonesian patients with ID. This study 
shows that subtelomeric rearrangements are an important cause of ID in Indonesia and 
its prevalence does not differ from previously reported studies in the Western world. 
Since diagnostic facilities for this kind of abnormalities are not yet available in 
Indonesia, the implementation of this technique in a routine diagnostic setting will help 
to establish a genetic diagnosis in individuals with ID, and will improve the possibilities 
for genetic counselling to the families involved. To establish an adequate diagnosis is of 
crucial importance for the patients and their families. Therefore, diagnostic facilities for 
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genetic diseases need to get a higher priority in Indonesia, similar to those for common 
infectious diseases and nutritional problems. 
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Abstract: 
Mowat–Wilson syndrome (OMIM 235730) is a genetic condition characterized by 
moderate-to-severe intellectual disability, a recognizable facial phenotype and multiple 
congenital anomalies. The striking facial phenotype in addition to other features such 
as severely impaired speech, hypotonia, microcephaly, short stature, seizures, corpus 
callosum agenesis, congenital heart defects, hypospadias and Hirschprung disease are 
particularly important clues for the initial clinical diagnosis.  All molecularly confirmed 
cases with typical MWS have a heterozygous loss-of-function mutation in the zinc 
finger E-box protein 2 (ZEB2) gene, also called SIP1 (Smad-interacting protein 1) and 
ZFHX1B, suggesting that haploinsufficiency is the main pathological mechanism. 
Approximately 80% of mutations are nonsense and frameshift mutations (small 
insertions or deletions). About half of these mutations are located in exon eight. Here, 
we report the first Indonesian patient with Mowat-Wilson syndrome confirmed by 
molecular analysis. 
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Introduction 
Mowat–Wilson syndrome (MWS; OMIM 235730) is a rare genetic condition 
described by Mowat et al. in 1998, who reported a series of six children with intellectual 
disability (ID), striking facial features, and variable multiple congenital anomalies (MCA) 
(Mowat et al., 1998). All molecularly confirmed cases with typical MWS have a 
heterozygous loss of function mutation in the zinc finger E-box protein 2 (ZEB2) gene, 
also called SIP1 (Smad-interacting protein 1), and ZFHX1B (Wakamatsu et al., 2001). 
To date, about 200 molecularly proven MWS cases with over 100 different ZEB2 
mutations have been reported (Evans et al., 2012).  
The facial features are the most important diagnostic clue for the initial clinical 
diagnosis and provide a hallmark for ZEB2 mutation analysis (Garavelli and Mainardi, 
2007). Establishing a molecular diagnosis is important for the patients and their families 
as it allows reliable genetic counseling for their families and a better clinical 
management of the patients. Here, we report the first Indonesian patient with 
molecularly confirmed MWS. 
Case presentation 
The patient was a nineteen-year-old male with severe ID. He was the third son 
of nonconsanguineous, healthy, Javanese parents and family history was 
unremarkable. The patient was born at term after an uneventful pregnancy with a 
weight of 3200 g (25th centile) and length 50 cm (50th centile). He showed hypotonia 
and delayed developmental milestones. He started to sit at 20 months of age. At two 
years of age, he developed recurrent generalized seizures and was commenced on 
valproic acid, which brought his epilepsy under control. He started to walk at four years 
of age and spoke his first words at the age of five years. He had recurrent otitis media. 
Speech consisted of only a few words and he often communicated using sign 
language. He showed happy behavior with frequent smiling. In addition, he showed 
repetitive hand movements. On physical examination, his weight was 45 kg (<3rd 
centile), height 161 cm (<3rd centile) and head circumference 53 cm (<3rd
 
 centile).  
Facial dysmorphisms included a long face, deep-set eyes, large eyebrows with medial 
flaring, hypertelorism, strabismus, saddle nose with prominent rounded nasal tip, 
prominent columella, low-set and posteriorly rotated ears, uplifted ear lobules, a 
prominent narrow pointed chin, a small mouth and prognathism (Figure 1). In addition, 
he had tapered and slender fingers, prominent interphalangeal joints, and bilateral pes 
planus. Generalized hypotonia and hyperreflexia were observed. Heart auscultation 
was normal.  
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Figure 1. Photograph of Indonesian patient with Mowat-Wilson syndrome. 
 
Our patient in his 19 years of age showed striking facial gestalts of MWS such as large eyebrows with 
medial flaring (a) and uplifted ear lobules (b). Other dysmorphisms such as long face, deep-set eyes, 
upward slanting palpebral fissures, hypertelorism, strabismus, saddle nose with prominent rounded 
nasal tip, prominent columella, low-set and posteriorly rotated ears, prominent and triangular pointed 
chin, small mouth, full lips, and prognathia are noted. 
The individual was part of a larger series of 527 Indonesian individuals with ID 
from schools and institutions, whose conventional karyotyping, FMR1 gene analysis 
and subtelomeric MLPA were normal (Mundhofir et al., 2012). Based on the clinical 
features, MWS was suspected. Therefore, molecular analysis of the ZEB2 gene was 
warranted. Sanger sequencing of all coding exons and surrounding splice sites of the 
ZEB2 gene  was performed as described below. The genomic DNA reference 
sequence was NM_014795.2. PCR of exon eight was performed using primers 
CTTTACTTGGGTTTCCCACC (forward) and GGGGCTTGTCATTCCTT (reverse). One 
hundred nanograms of DNA solution (1 μL) was added into PCR mixture, which 
contained 7.6 μL of 360 PCR master mix (Applied Biosystem), 0.5 µL of primers 
working solution, and 6 µL of H2O. Amplification was performed using PCR System 
9700 (Applied Biosystem) with the following protocol.  PCR was initiated by 10’ 
denaturation at 95oC, followed by 35 PCR Cycles (30’’ 95oC, 30’’ 60oC, 60’’ 72oC) and 
7’ final elongation at 72oC. The result was analyzed on ABI 3730 analyzer (Applied 
Biosystem). Sequence result was compared to published reference sequence 
(rs148709333) using SEQPilot software version 3.2.1.0 (JSI medical system). In exon 
eight, a nonsense mutation has been detected, changing a TAC codon (coding for a 
tyrosine) into a TAG stopcodon; c.1965C>G (p.(Tyr652*)) (nomenclature according to 
the HGVS guidelines; http://www.hgvs.org/mutnomen/) (Figure 2). To our knowledge, 
this mutation has not been reported before. 
A B 
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Figure 2: Electropherogram of molecular analysis in the patient sample. 
 
The upper panel shows the heterozygous c.1965C>G (p.Tyr652X) mutation and the lower panel shows 
the wild type (control). The “S” on the electropherogram represents the C/G heterozygote. 
Discussion 
This is the first report of an Indonesian individual with MWS confirmed by 
molecular genetic testing. Although nonsense mutations account for more than 40% of 
known ZEB2 mutations and approximately 50% of these are localized in exon eight 
(Dastot-Le Moal et al., 2007), the particular mutation detected in the patient described 
in this paper (c.1965C>G; p.Tyr652*) has not been reported before.  
Most clinical features of our patient, who had severe ID, a distinct facial gestalt, 
microcephaly, and seizures, are consistent with those described in the literature (Table 
1). Brain imaging and echocardiography could not be performed since he is living in the 
country with minimal health facilities. Symptoms of Hirschprung disease (HSCR) such 
as constipation, dysphagia, and poor appetite were not reported in our patient, but the 
prevalence of these symptoms in other publications ranged from the majority of 
individuals (Mowat et al., 1998; Wakamatsu et al., 2001) to 50% of cases (Dastot-Le 
Moal et al., 2007; Garavelli and Mainardi, 2007). Early diagnosis, intervention, and 
targeted management are necessary for a better health and life quality of individuals 
with MWS. However, as this syndrome is rare and recently described, the knowledge of 
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the clinical complications and natural history is still developing (Mowat and Wilson, 
2010).  
Table 1: Clinical features of our patient compared to those in published cases of 
MWS with proven ZEB2 mutations. 
 
Clinical features  Our patient  
Mowat-
Wilson 
syndrome∗  
ZEB2 mutations  +  100%  
Intellectual disability  +  100%  
Typical facial gestalt  +  97%  
Microcephaly  +  81%  
Seizures  +  73%  
HSCR  −∗∗  57%  
CHD  −∗∗  52%  
Hypospadias  −  52%  
Short stature  +  46%  
Hypoplasia or agenesis 
of CCA  NT  43%  
Cryptorchidism  −  36%  
Constipation  −  26%  
Pyloric stenosis  −  4.7%  
Eye anomalies  −  4.1%  
Cleft palate  −  2.9%  
∗ Adapted from Garavelli and Mainardi (2007). 
∗∗ Symptoms not observed although the gold standard diagnosis has not 
been performed. 
NT: not tested, HSCR: Hirschprung disease, CHD: congenital heart 
defect, CCA: Corpus Callosum. 
 
In summary, we report the first Indonesian MWS case with a novel ZEB2 
mutation. Our patient showed similar dysmorphism to previously reported cases, 
although several major associated features were not present such as HSCR, congenital 
heart defect (CHD) and hypospadia. Despite the availability of molecular diagnostic 
tests in several parts of the world, the recognition of clinically well defined syndromes 
will remain very important in countries with limited diagnostic facilities such as 
Indonesia. The publication of cases with recognizable facial features is therefore of 
great importance in order to make local pediatricians aware of rare conditions like 
Mowat-Wilson syndrome, allowing more clinical diagnoses in the future. 
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Abstract 
Background 
Intellectual disability (ID) often coincides with an abnormal head circumference (HC).  
Since the HC is a reflection of brain size, abnormalities in HC may be a sign of a brain 
anomaly. Although microcephaly is often secondary to ID, hereditary (autosomal 
recessive) forms of primary microcephaly (MCPH) also exist that result in ID.  
Objective 
To investigate mutations in MCPH genes in patients with ID and microcephaly. 
Methods 
From a population of 527 Indonesian ID individuals, 48 patients with microcephaly 
(9.1%) were selected. These patients were previously found to be negative upon 
conventional karyotyping, FMR1 gene analysis and subtelomeric deletion and 
duplication MLPA. Sanger sequencing for ASPM and WDR62 was performed in all 48 
samples, while sequencing for MCPH1, CDKRAP2, CENPJ and STIL was conducted 
only in 20 samples with an OFC below -4SD. 
Results 
In all genes investigated, 66 single nucleotide polymorphisms (SNPs) and 15 
unclassified variants which were predicted as unlikely to be pathogenic (UV2) have 
been identified. Possible pathogenic variants (UV3) have only been identified in ASPM 
and WDR62.  However, since none of the patients harboured compound heterozygous 
likely pathogenic mutations, no molecular diagnosis of MCPH could be established. 
Interestingly, one of the patients harboured the same variants as her unaffected 
monozygotic twin sister, indicating that our cohort includes a discordant twin. 
Conclusions 
This is the first study to identify genetic causes of MCPH in the Indonesian population. 
The absence of causative pathogenic mutations in the tested MCPH genes might 
originate from several factors. The identification of UV2 and UV3 variants as well as the 
absence of causative pathogenic mutations calls for further investigations. 
Keywords: Intellectual disability (ID), microcephaly, MCPH genes, Sanger sequencing, 
Indonesia 
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Introduction 
Intellectual disability (ID) has been estimated to have a prevalence close to 3% 
worldwide and has a variety of genetic causes (van Bokhoven, 2011). In patients with 
ID, an abnormal head circumference (HC) is often another main sign (Mochida, 2009; 
Kaindl et al., 2010). Since the HC or occipitofrontal circumference (OFC) is a reflection 
of brain size, abnormal head circumference may be a sign of a brain anomaly. 
Microcephaly is commonly classified as HC below minus two standard deviations (SD) 
or below the 2nd
The aetiologies of microcephaly can be divided into genetic causes and 
environmental insults to the brain during prenatal, perinatal, or early postnatal period 
(Tarrant et al., 2009). Primary microcephaly/congenital microcephaly is described as a 
static developmental abnormality which presents at birth or as early as 32 weeks of 
gestation (Woods, 2004). Secondary microcephaly is considered as a progressive 
neurodegenerative condition where the head circumference at birth is within normal 
range and microcephaly develops thereafter (Woods, 2004; Abuelo, 2007). The 
presence of microcephaly at birth is one of the signs of genetic microcephaly (Mochida, 
2009). Until recently, eight loci associated with autosomal recessive primary hereditary 
microcephaly (MCPH1-MCPH8) have been found and causative mutations have been 
identified in the 8 MCPH genes. Details of known autosomal recessive primary 
microcephaly (MCPH) genes are summarized in Table 1.  
 centile for the patient’s age and gender (Opitz and Holt, 1990; Leviton 
et al., 2002). Its incidence at birth is between 1.3 and 150 per 100,000 live births 
(Kaindl et al., 2010).  
Several mutations have been identified in these loci in different countries 
(Wollnik, 2010; Soltani Banavandi et al., 2012; Hussain et al., 2012b). However, as no 
genetic analysis has been performed in the Indonesian population, this study aimed at 
investigating the presence of mutations in those genes. The understanding of possible 
genetic causes of microcephaly associated with ID in the Indonesian population is 
expected to assist appropriate aetiological diagnosis and genetic counselling in the 
affected individuals and their families.  
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Methods 
Samples were selected from a cohort of 527 ID individuals in whom physical 
examinations, dysmorphology assessments, blood collections and several genetic 
screenings were performed (Mundhofir et al., 2012). Peripheral duplicate blood 
samples in EDTA and Heparin were collected from these individuals. Several genetic 
screenings including cytogenetic analysis, FMR1 gene and subtelomeric 
rearrangements were carried out (Mundhofir et al., 2012). A total of 48 individuals 
whose cytogenetic analysis, and tests for FMR1 gene and subtelomeric 
rearrangements turned out to be normal and whose HC measurement was less than -2 
standard deviation (microcephaly) measured with the Nellhaus charts (Nellhaus, 1968) 
were included in this study. Informed consent was obtained from their parents or legal 
representatives; and the study was approved by the Ethical Board of the University of 
Diponegoro/Kariadi Hospital Semarang, Indonesia. Clinical characteristics of the 
studied population are summarized in Table 2. 
Table 2. Characteristics of ID individuals with microcephaly (n = 48) 
Characteristics  n  %  
Sex 
Female  23  47.9  
Male  25  52.1  
Level of ID   
Mild 22 45.8 
Moderate 17 35.4 
Severe 9 18.8 
OFC    
-2SD<n<-3SD  6  12.5  
-3SD<n<-4SD  22  45.8  
<-4SD  20  41.7  
Associated abnormalities 
Epilepsy  7  14.6  
 
Genomic DNA of each patient was isolated using salting out method DNA 
extraction as described elsewhere (Miller et al., 1988) with slight modification. Sanger 
sequencing for ASPM and WDR62 was performed in all 48 ID samples. Considering 
the low prevalence of the remaining MCPH genes (MCPH1, CDKRAP2, CENPJ and 
STIL) in the beginning of our study the sequencing of these 4 genes was conducted 
only on 20 samples with the lowest OFC (below -4SD). CEP152 and CEP135 were not 
sequenced in this study as they have recently been discovered. PCR products of all 
coding exons were generated using standard techniques. Sequences of the PCR 
primers are available upon request. In brief, 1 µL DNA (~100 ng) from each sample was 
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diluted in a PCR mix solution, consisting of 7.6 µL of 360 PCR mix (Life Technologies, 
Foster City, USA), 0.5 µL of each primer (Biolegio, Nijmegen, The Netherlands) and 6 
µL of purified water. The mixture was amplified in a 9700 Veriti PCR system (Life 
Technologies, Foster City, USA) using the following protocol: initial denaturation at 
95ºC for 10’ was followed by 35 cycles of 94ºC for 30”, 60ºC for 60” and 72ºC for 60”, 
and ended with elongation at 72ºC for 1’. Subsequently, the PCR products were 
purified using Millipore columns according the protocol recommended by the 
manufacturer (Merck Millipore, New Jersey, USA). One µL of purified PCR product was 
mixed with M13 primer (forward or reverse). Amplification and purification step were 
performed according the protocol recommended by the manufacturer and was then 
analyzed on an ABI 3730 XL sequencer (Life Technologies, Foster City, USA). 
Sequence variations in the DNA of the patients were compared to the 
reference sequence in Ensembl assembly GRCh37 (GCA_000001405.6) from the 
Genome Reference Consortium (http://www.ncbi.nlm.nih.gov/projects/genome 
/assembly/grc/human/index.shtml) using the following reference sequences: ASPM 
(NM_018136.4) WDR62 (NM_001083961.1), MCPH1 (NM_024596.3), CDK5RAP2 
(NM_018249.4), CENPJ (NM_018451), and STIL (NM_001048166). The DNA 
sequencing data were analyzed with SEQPilot software version 3.2.1.0 (Softgenetics, 
Pennsylvania, USA
For one of the patients and her family, an identifiler test was conducted in a 
follow up study using AmpFlSTR Identifiler Direct PCR Amplification Kit (Life 
Technologies, Foster City, USA) using the manufacturer’s protocol. 
). Variants were further analyzed using Alamut 2.0 mutation 
interpretation software (Interactive Biosoftware, Rouen, France). The impact of protein 
alteration was calculated using Align-GVGD method (http://agvgd.iarc.fr/), SIFT 
(http://sift.jcvi.org/), and Polyphen (http://genetics.bwh.harvard.edu/pph2/). The variants 
found in this study were then classified according to the guidelines of the UK Molecular 
Genetics Society (CMGS) and the Dutch Society of Clinical Genetic Laboratory 
Specialists (Vereniging Klinisch Genetische Laboratoriumspecialisten). The 
classifications are: Class 1 (UV1)=Certainly non pathogenic; Class 2 (UV2)=Unlikely to 
be pathogenic; Class 3 (UV3)=Likely to be pathogenic and Class 4 (UV4)=Certainly 
pathogenic.  
Results 
In this study, a total of 186 amplicons were sequenced, including the 
sequencing of ASPM and WDR62 in 48 samples and MCPH1, CDKRAP2, CENPJ and 
STIL in 20 samples. In ASPM and WDR62 a total of 26 unclassified variants have been 
identified, 15 of which were predicted as unlikely to be pathogenic (UV2), 10 were 
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predicted as likely to be pathogenic (UV3) and one which could not be classified. In 
addition, 15 and 13 single nucleotide polymorphisms (SNPs) (classified as certainly not 
pathogenic (UV1)) were identified in the ASPM and WDR62 gene, respectively. In the 
remaining genes, only known SNPs have been identified: 15 MCPH1 variants, 14 
CDKRAP5 variants, 6 CENPJ variants and 3 STIL variants. Since MCPH is an 
autosomal recessive disease, only the presence of homozygous or two compound 
heterozygous mutations would explain the phenotype. Only one of the patients 
harboured two ASPM variants that were classified as UV3. A follow up study in the 
family was needed to investigate if these variants reside on different chromosomes. 
Sequence analysis of the variants in both parents and a twin sister revealed that both 
variants were present in the unaffected father and twin sister, indicating that they are 
present on the same chromosome and do not explain the phenotype in the patient. To 
exclude the possibility of an unidentified mutation in the second (maternal) allele, an 
identifiler test was performed to examine whether the twins were dizygotic or 
monozygotic. Interestingly, the result showed that the twin sisters were monozygotic, 
which makes autosomal recessive inheritance of the condition in this family highly 
unlikely. 
Discussion 
This is the first study to identify the genetic cause of microcephaly associated 
ID in the Indonesian population. Albeit pathogenic mutations were not found, the 
identification of numerous single nucleotide polymorphisms (SNPs) may be useful in 
future association studies in our population. In addition, it has not been excluded that 
some of the UV3 variants might turn out to be pathogenic. 
An interesting finding in this study included the identification of a monozygotic 
twin in which only one of the sisters was affected. Underlying mechanisms to contribute 
to this so called twin discordance phenomenon are alterations in gene structure and 
expression during meiosis and/or mitosis, epigenetic changes or phenocopy (Miller et 
al., 2012). As the variants were also identified in the unaffected father and the 
unaffected monozygotic twin sister, autosomal recessive primary microcephaly turned 
out to be a highly unlikely diagnosis in the affected sister. Therefore, it is expected that 
the disease is more likely caused by a de novo mutation with a low recurrence risk for 
future children of the parents. This knowledge is not only useful for counselling in the 
family, but paves the way for future identification of the genetic defect in this family, e.g. 
by exome sequencing comparing the genotypes of the two twin sisters. 
The absence of causative pathogenic mutations in the MCPH genes 
investigated in this study might be due to several reasons. First, the microcephaly and 
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ID in these individuals might not be genetic. Several non-genetic factors, such as 
undernutrition, infections, ischaemia, metabolic disturbances, exposure to toxic 
substances, and trauma are known to play a role in microcephaly (Tarrant et al., 2009; 
Jauhari et al., 2011). As there is limited information on the onset of the microcephaly in 
these individuals (birth HC measurement is hardly available), non-genetic factors could 
not be ruled out. Second, microcephaly in these individuals may due to secondary 
microcephaly. Third, there is a possibility that causative mutations are present in the 
tested genes, but were missed or were not recognized by the methods utilized in this 
study. For example, the presence of exonic or whole gene deletions has not been 
investigated, since only direct sequencing has been performed (Thornton and Woods, 
2009; Mahmood et al., 2011). Fourth, there is a chance that the microcephaly may 
result from mutations in genes that have not yet been discovered, since more than half 
of reported families with MCPH have not been linked to any of the eight MCPH loci (see 
Table 1). Fifth, there is a possibility that the genetic defects occur in CEP152 and 
CEP135 that were not investigated in this study.  
The overall frequency of microcephaly with ID in this study was 9.1% (48/527). 
This is comparable to studies performed in other Asian ID populations such as the 
Indian (9.8%) (Jauhari et al., 2011) and Israeli (15.4%) (Watemberg et al., 2002) 
populations. However, the frequency of microcephaly in this study might have been 
overrated. The mean value of height and weight of Indonesian children in the 
nationwide survey was smaller compared to the United States of America Centers for 
Disease Control and Prevention growth charts (Batubara et al., 2006). Considering the 
correlation between height and weight and head circumference, Indonesian individuals 
are expected to have a smaller HC. In addition, in a pilot study conducted in Semarang, 
Central Java, the mean value of the head circumference of Indonesian normal school 
children aged 7-12 was smaller than the normal range of the Nellhaus charts 
(unpublished observations). The mean values of boys (n=128) were between the 3rd  
and 50th centile while of the girls (n=146) these were between the 10th and 50th
To conclude, this is the first large-scale study to identify genetic causes of 
microcephaly with ID in the Indonesian population. This study shows that the frequency 
of microcephaly and ID is not much different from previously reported studies in Asian 
populations. The absence of causative pathogenic mutations in the tested MCPH 
genes might originate from several factors such as non-genetic factors, secondary 
microcephaly and mutations in other genes that were not investigated in our study. The 
identification of UV2 and UV3 variants as well as the absence of causative pathogenic 
mutations calls for further investigations, such as sequencing of other MCPH genes 
 centile. 
For a better estimation of the incidence of microcephaly, future studies are required to 
establish a normal HC chart for the Indonesian population. 
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(CEP152 and CEP135) and whole exome sequencing  study, preferably in a larger and 
better defined sample.  
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The work described in this thesis is a continuation of the first screening study 
of ID in a large cohort of Indonesian individuals (Hussein, 1998; Faradz et al., 1999). 
The previous study was carried out using conventional cytogenetic and FMR1 gene 
analyses with the main focus on males. This thesis, however, characterizes and 
discusses the results of a comprehensive genetic-aetiological survey of individuals with 
ID carried out in the nation and provides a protocol for diagnostic work up in Indonesia. 
6.1. Diagnostic investigation in Indonesian ID individuals  
6.1.1. The yields of aetiological genetic assessments in the Indonesian ID 
population 
 
The identification of several genetic abnormalities has revolutionized the 
diagnostic process of patients with ID. Nowadays, the development and implementation 
of novel methodologies have shown that genetic abnormalities are important causes of 
ID. As genetic aetiological tests are rarely performed, we carried out some genetic 
analyses in undiagnosed Indonesian ID individuals. We performed cytogenetic analysis 
using conventional karyotyping with confirmation by some stand-alone molecular tests. 
We identified cytogenetic abnormalities in 16.5% (87/527) patients, demonstrating that 
cytogenetic abnormalities are one of the major genetic causes of ID in our cohort 
(Chapter 2).  
In order to establish the frequency of FXS in male and female ID Individuals, 
we investigated the promoter region of the FMR1 gene in Indonesian ID individuals 
using PCR based fragment length analysis, with confirmation of expanded alleles by 
Southern blot and repeat-primed PCR methods. The detection rate of FXS was 1.7% 
(9/527) with a frequency in males and females of 1.5% (5/329) and 2% (4/198), 
respectively. Moreover, we documented relatives with the same disorder, 
demonstrating that FXS is an important cause of inherited ID in our cohort (Chapter 3).  
Deletions and duplications of subtelomeric regions are an important cause of 
unexplained cases of ID. These abnormalities have not been investigated in Indonesian 
ID individuals. In order to determine the frequency of subtelomeric rearrangements in a 
cohort of Indonesian ID individuals, who had a normal karyotype and who were FXS 
negative, we performed MLPA analysis with probes in all subtelomeres. We identified 
clinically relevant rearrangements in 3% (16/527) of them, demonstrating that 
subtelomeric rearrangements are important causes of unexplained ID in our cohort 
(Chapter 4.1). Moreover, in one of these individuals, we identified familial monosomy 
9pter and trisomy 9q34.11qter in two sisters, due to a maternal pericentric inversion 
(Chapter 4.2).  
The latest meta-analysis study of genetic screening yields in the ID individuals 
comprised 367 out of 7,000 genetic screening studies between 1980–2009. It was 
reported that the frequency of chromosome aberrations was 4.2% and 18.6% for non-
syndromic and syndromic ID, respectively.  
In their study, the detection rate of FXS was 2%, and the frequency of 
subtelomeric rearrangements was 0.5% and 7.4% for individuals with milder and 
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moderate/severe impairments, respectively (Michelson et al., 2011). The detection 
rates of chromosome aberrations, FXS, as well as subtelomeric deletions, in our study, 
are comparable with this meta-analysis.  
A total of 72 out of 74 (97.3%) of DS individuals were diagnosed clinically, 
whereas 7 of 9 individuals (77.8%) were clinically suspected of having FXS. Although 
Down syndrome and FXS can be diagnosed on clinical grounds, these affected ID 
individuals in this cohort had not been cytogenetically and molecularly investigated. 
This explains why a relatively high frequency of Down syndrome and FXS was 
identified in this study (14% and 2% respectively) (Chapter 2 and 3). 
In some of the ID individuals in our cohort, the combination of clinical features 
suggested the presence of a specific syndrome. In order to confirm this hypothesis, we 
performed molecular testing of the genetic defect involved in these syndromes. The first 
Indonesian patient with Mowat-Wilson syndrome was molecularly diagnosed (Chapter 
5.1). In a larger subgroup of individuals with microcephaly, however, no pathogenic 
mutations could be identified in the genes responsible for this disorder (Chapter 5.2). 
Molecular screening on PW/AS could not identify genetic abnormalities in a 
subgroup of individuals with clinical suspicion of these syndromes in our population. 
The low frequency of PW/AS which has been reported to be 0.2–0.4 % in the ID 
population might be a plausible explanation why individuals with PW/AS could not be 
identified in this study (Stevenson et al., 2003; Rauch et al., 2006). Negative findings in 
the series of molecular analyses performed in subgroups of individuals with 
microcephaly/macrocephaly and epilepsy might be due to several factors, either 
genetic or non-genetic. First, there are several non-genetic factors which have been 
attributed to play a role in epilepsy, microcephaly and macrocephaly (Ivanovic et al., 
2004; Tarrant et al., 2009; Ono and Galanopoulou, 2012). Second, the negative 
findings in the coding regions of the investigated genes indicate that mutations in these 
genes have a very low frequency, at least in our population. Third, it is suggested that 
genetic factors other than mutations in these genes might be involved in the aetiology 
of these conditions. Finally, another point of consideration is that we cannot rule out the 
presence of deep intronic mutations, promoter mutations, deletions or duplications in 
these genes, because these have not been investigated.  
The total yield of aetiological diagnoses in this study was 20.5% (108/527), 
leaving 79.5% of individuals without a diagnosis. This percentage is comparable with 
the 21.8% (124/570) genetic diagnoses reported by Rauch et al., (2006) (excluding the 
molecular karyotyping result). Compared with the study conducted by Stevenson et al. 
(2003) in larger cohort of ID individuals, the number of diagnosis in our study is 
significantly lower (p<0.005). In their study, in more than 40% of cases a diagnosis 
could be assigned. This difference, however, can easily be explained by the fact that 
also non-genetic factors such as environmental insults, infection, exposition to chemical 
substances and prematurity were evaluated. Moreover, some factors such as 
multifactorial and culturofamilial were determined. In addition, metabolic studies and 
neuroimaging studies were conducted in their study as well. The evaluation of non-
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genetic factors, and metabolic and neuroimaging studies, however, were not conducted 
in our population. If metabolic studies and neuroimaging investigations had  been 
performed in our population, this could have added an approximate 3.7%–4.6% of 
aetiological diagnosis (Michelson et al., 2011). 
The use of state-of-the-art genetic analyses such as microarray analysis and 
NGS might increase the number of diagnosis in ID Individuals even further. It is 
estimated that microarray analysis adds approximately 12% of aetiological diagnoses 
(Miller et al., 2010; Cooper et al., 2011). Furthermore, investigation using WES would 
tally up another 8-16% of aetiological diagnosis (Dixon-Salazar et al., 2012; de Ligt et 
al., 2012). So, the total yield of aetiological diagnoses would be in the order of 44-53%. 
Further investigations in future studies, therefore, are warranted. 
6.1.2. Establishing a diagnosis: a challenge in Indonesia 
Understanding the challenges of establishing a diagnosis for ID individuals in 
Indonesia requires comprehensive reflection on the complex relationship between 
government policies, public healthcare systems, socio-cultural factors, economics and 
education. Government health policies in Indonesia continue to focus on infectious 
diseases, while limited attention is given to chronic and non-communicable disorders 
such as neurodevelopmental disorders. Consequently, the services for such disorders 
are disproportionately underfunded. 
Starting from the last five years, the Government of the Republic of Indonesia 
has been providing health and social security insurance for the poor. However, the 
insurance is limited to basic medical costs. Sophisticated examinations such as brain 
imaging and genetic analysis, unfortunately, are not yet covered by such insurance. In 
addition, these health facilities often have minimal equipment and are only available in 
big cities. In some areas of Indonesia, individuals with ID and their families are still 
being stigmatized (Komardjaja, 2005). Therefore, parents tend to hide them from 
community. This, together with the high cost of special education that is not covered by 
the government, is the reason why a large number of individuals with ID stay at home 
without proper education and training. Consequently, they remain unidentified as such. 
Neonatal screening has not been established yet as a health policy in Indonesia due to 
lack of facilities, funding and human resources. Therefore, the incidence of preventable 
causes of ID identified by newborn screening remains unknown. It should be noted, 
however, that metabolic disorders causing ID such as congenital hypothyroidism are 
not uncommon (Rustama et al., 2003). In the health sector, the lack of medical 
personnel’s knowledge and awareness of genetics and the virtual absence of clinical 
geneticists within the country complicate further diagnosing ID individuals. In addition, 
genetic research and its funding are very inadequate.  
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6.2. Implication of genetic aetiological diagnosis of ID individuals 
The identification of the aetiology of ID is of major importance for patients and 
their families. Establishing a diagnosis means giving clear answers for the frequently 
asked questions among parents about what their offspring “have”. In majority of cases, 
therefore, it allows answers to multiple questions about causation and pathogenesis, 
recurrence risk, and early application of therapeutic and educational interventions 
(Baker et al., 2012). In addition, it aids family’s grieving and adaptation, as well as 
facilitates connections within groups/families with similar disorders (Lopez-Rangel et 
al., 2008). 
Parents of children with ID of unknown aetiology will face one of the greatest 
challenges, i.e. searching for explanations “why it happened”. After the diagnosis of ID 
in their children, parents often showed initial reactions such as ambivalence, anger, 
confusion, self pity, blame, feelings of helplessness, depression, disappointment, grief, 
guilt, mourning, impulses to kill the child and suicidal impulses (Mary, 1990; Majumdar 
et al., 2005). The result of aetiological diagnosis sometimes helps to fade away these 
initial feelings. This will be followed by a reaction stage, in which they show emotion of 
denial, sadness, and anger. Gradually, parents will enter an adaptation stage where 
they begin to ask questions about what to do, and finally a reorganization stage where 
they seek help and begin to plan ahead (Mary, 1990; Majumdar et al., 2005). In this 
stage, again, aetiological diagnosis plays a role because it allows answers to parents’ 
multiple questions on management and prognosis. For medical practitioners, an 
aetiological diagnosis assists them to provide a general prognosis and treatment 
options and gives them the opportunity to counsel the individual/family regarding 
prospective health care needs and reproductive planning. In complicated patients, such 
as individuals with ID and MCA, it also allows a multidisciplinary medical management 
approach in which unnecessary, invasive and costly investigations and testing can be 
avoided. In addition, early prevention as well as early intervention for co-morbidities can 
be well planned (Lopez-Rangel et al., 2008). Caregivers and educational specialists 
may take benefits from the aetiological diagnosis. They can access additional 
resources for individuals with ID based on a specific diagnosis and known 
developmental and medical profile. In addition, they may be able to provide access to 
therapeutic recreational programmes, social programmes and group support for 
affected individuals as well (Baker et al., 2012). 
There is no reason to believe that the above mentioned implications of 
establishing a diagnosis in individuals with ID are less important in Indonesia, 
compared to the rest of the world. By providing evidence of an important genetic 
contribution to the cause of ID, our study will strengthen the position of medical 
genetics in Indonesia and enhance genetic awareness of the Indonesian medical 
profession and the public at large. In addition, this hopefully will trigger the government 
to pay more attention to medical genetics, particularly on research funding and 
providing better facilities for genetic services in the public health system. To date, 
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genetics is still not incorporated in the curricula of Indonesian medical education. The 
results of our study will hopefully stimulate the Indonesian medical association and/or 
medical specialist collegiums to incorporate genetics into the medical education as well 
as into the training program for other health workers. The medical specialist collegiums 
play a significant role in determining curricula for training and education of each 
medical specialist. 
 
6.3. Diagnostic protocol for Indonesia 
 6.3.1. Clinical guideline for the Indonesian setting 
 
As no clinical guideline exists for the evaluation of ID individuals in Indonesia, 
establishing one for local use was one of the aims of this study. At the initial stage of 
this study, the clinical guidelines of the RUNMC Genetic Department, The Netherlands 
have been adopted and utilized to evaluate ID individuals. These guidelines are in 
accordance with existing guidelines of the American College of Medical Genetics and 
systematic studies of (Curry et al., 1997; van Karnebeek et al., 2005). Adaptations and 
improvements, however, need to be considered to adjust for local use. Mainly, this 
clinical guideline is intended to be utilized for routine use by paediatricians, neurologists 
and medical geneticists in evaluating individuals with ID. However, it can also be 
utilized for research purposes and by other medical workers.  
The first step is exploring the essential elements of the affected individual’s 
history that include a three-generation pedigree, and pre-, peri-, and postnatal history. 
A three-generation pedigree should be carefully taken. The presence of relevant clinical 
characteristics should be noted in family members, such as abnormal mental 
development and/or MCA (important clues for aetiology), psychiatric disorders, 
recurrent miscarriages (hint for chromosomal translocation), increased age of affected 
individual’s parent (suspicion to spontaneous mutations), consanguinity (sign for 
autosomal recessive disorders), head circumference and education of parents 
(indication for normal family intelligence level). Careful history taking will include the 
pre- and perinatal history and care, especially questions concerning possible 
teratogenic exposures (alcohol, cigarettes, pesticides, herbal and/or alternative 
medicines, medications and radiography), maternal diabetes or infectious diseases 
during pregnancy as well as the amount of amniotic fluid and child movements (Curry 
et al., 1997; van Karnebeek et al., 2005). The presence of more similarly affected 
individuals in the family may highlight a distinctive pattern of inheritance, and may 
provide clues for a particular genetic disease. For example, an X-linked pattern may 
indicate that the Fragile-X syndrome is running in the family.  
The information on the perinatal period will include length, weight and OFC at 
birth, signs of asphyxia/APGAR score, feeding and sleeping patterns as well as 
hypotonia in early life. The information on the postnatal period will include further 
weight, height and OFC curves as well as the developmental milestones. Specific 
attention should be paid to loss of already gained skills. A history of trauma, injury, 
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medication as well as illness history in the postnatal period should be noted. Co-
morbidity with other cognitive disorders - more frequent in ID individuals - should be 
identified, as it can facilitate the diagnostic process by permitting classification of ID 
patients into specific subgroups (i.e. autism, ADHD, epilepsy) (Curry et al., 1997; van 
Karnebeek et al., 2005). In Indonesia, history taking is often challenging. The parent’s 
education level contributes to the success of history taking. Prenatal care is still 
considered as an uncommon practice, particularly in suburban and rural areas. 
Therefore, the information about the prenatal period is sometimes difficult to obtain. 
Many parents do not have or often forget the basic birth records such as weight, length 
and OFC, as they often give birth in their own house without attendance of medical 
personnel. In many cases, parents do not pay attention to their children’s 
developmental milestones. Socio-cultural factors also complicate history taking, for 
instance, parents often associate the condition of their children with myth or belief. 
Likewise, parents are not always available as they might, in order to avoid 
embarrassment, have entrusted their ID child to the grandparents or to other relatives 
without giving them relevant data.  
The next important step is physical examination. It should start with general 
physical measurements such as weight, height, head circumference (OFC), outer 
canthal distance (OCD), inner canthal distance (ICD), inter pupillary distance (IPD), ear 
length, total hand length (THL), palm length (PL), and -in males- testicular volume 
(Curry et al., 1997; van Karnebeek et al., 2005).  Some other measurements, such as 
arm span and sitting height, should be performed if there is a suspicion of a specific 
condition. Important landmarks for the measurements can be found in Hall et al., 
(2007). Measurement results for height and weight, can be plotted to the normal graph 
of measurements which are now available for the Indonesian population (Batubara et 
al., 2006). This normal graph for Indonesian children is based on a nationwide survey, 
in which data from approximately 35,000 Indonesian children were compared to the 
United States of America Centers for Disease Control and Prevention (CDC) growth 
charts by calculating their individual standard deviations out of the SD reference values 
for the American population. A mean difference of -1.47 SDS for boys and -1.43 SDS 
for girls was found. Since the measurements of Batubara et al. (2006) only include OFC 
data for infants below 1 year of age, OFC measurements in this study were plotted to 
the Nellhaus’ head circumference chart (Nellhaus, 1968). The choice to use the 
Nellhaus’ charts is based on their mixed racial population sample, their frequent use in 
clinical settings, and the age range covered by these charts (Miles, 2000). However, we 
had the impression that the OFC of Indonesian children was generally lower than the 
mean values in the Nellhaus’ charts. Indeed, our pilot study conducted in Semarang, 
Central Java, indicated that the mean value of head circumference of Indonesian 
normal school children aged 7-12 years is smaller compared to the normal range of the 
Nellhaus charts. The boys' mean value (n=128) was between the 3rd and under 50th 
percentile, while for girls (n=146) it lied between the 10th and under 50th percentile 
(Mundhofir et al, unpublished observations). The other measurements such as ICD, 
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IPD, OCD, ear length, can be plotted to the normal measurement graph published by 
(Hall et al., 2007). However, it is possible that the anthropometrical data for the 
Indonesian population might differ from those of other populations, which is supported 
by the study on length and weight of Batubara et al. (2006) and our pilot study on OFC.  
The following step is clinical examination that comprises general habitus and 
dysmorphological assessment of craniofacial, thorax, abdomen, back, genitalia, upper 
and lower extremities (van Karnebeek et al., 2005; Baker et al., 2012). In an effort to 
make the dysmorphological terminology reliable and reproducible, the clinician should 
refer to the standard nomenclature formulated by an international group of clinicians 
working in the field of dysmorphology (Allanson et al., 2009; Biesecker et al., 2009; 
Carey et al., 2009; Hall et al., 2009; Hunter et al., 2009; Hennekam et al., 2009). A 
general neurological investigation is important since it may be a clue to a specific 
neurological condition. For instance, spasticity is invariably found in individuals who 
have had perinatal asphyxia or cerebral palsy. Likewise, it is important to pay attention 
to the skin and its appendages as it may be a clue to specific conditions such as 
neurofibromatosis or tuberous sclerosis (Seibert et al., 2011). Examining both vision 
and hearing is essential as disturbances of one or both have major implications for 
management and are often part of a recognizable syndrome (Sullivan et al., 2011). 
Abnormal behaviour should be noted as it may give clues to the aetiology of the ID (Dai 
et al., 2012; van Balkom et al., 2012; Marschik et al., 2012). A tool for the description of 
behaviour by Shalev and Hall, (2004) can be used. Finally, standard clinical pictures 
should be taken including standard face, side face, general body profile, side body 
profile, hands and feet. Pictures of other specific structures are only indicated if there is 
a peculiar appearance or dysmorphism.  
Although the DSM-5 proposal does not list IQ test score requirements in the 
formal diagnostic criteria, it continues to specify that standardized psychological testing 
must be included in the assessment of ID individuals (American Psychiatric 
Association, 2012). Therefore, the next step is confirming the existence and the 
determination of the severity of disability by formal IQ testing. 
6.3.2. Genetic, metabolic, and neuroimaging guidelines 
Based on the results of this study, for routine practice and for future empirical 
studies aiming at detecting the aetiological diagnosis in individuals with ID, the 
guidelines on genetic, metabolic, and neuroimaging can be formulated as follows: 
a. In each individual, standard cytogenetic testing including fragile site screening 
should be performed, regardless of the degree of ID and the presence of 
dysmorphic features (Shaffer, 2005). The main reason for this is that 
cytogenetic analysis has the highest yield in the Indonesian population (basis: 
this study). Moreover, cytogenetic analysis is available and considered to be 
affordable. The analysis can be skipped only if non-genetic causes of ID are 
evident through history taking and physical examination. For individuals with 
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clinical features of a known chromosomal abnormality syndrome such as Down 
syndrome, still cytogenetic analysis should be performed, because the actual 
cytogenetic diagnosis may affect the recurrence risk (Shaffer, 2005).  
b. Molecular studies for FXS should be performed if the cytogenetic analysis is 
normal, regardless of sex, degree of ID, and the presence of associated 
features of FXS (basis: this study). Although the chance to identify FXS is ~1-
3%, the detection remains of paramount importance because of its X-linked 
inheritance and therefore pertinent consequences for families. In addition, the 
presence of clinical features is sometimes subtle, particularly in women. The 
analysis can be skipped only if clinical features are strongly pointing to a 
specific known syndrome. The PCR based CGG repeat FMR1 gene analysis is 
available in Indonesia and considered to be affordable.  
c. Molecular studies for submicroscopic rearrangements should be considered in 
the future if cytogenetic analysis and FXS analysis are normal. The facilities to 
detect such aberrations are not yet available in Indonesia; however, in the near 
future, these will be available. Although setting up MLPA analysis for the 
detection of subtelomeric aberrations would lead to the detection of 3% of ID 
causes (this study), it might be a better option to invest money in high 
resolution genome wide approaches (like SNP array). These techniques will be 
able to detect submicroscopic deletions and duplications throughout the 
genome, including the subtelomeric regions. 
d. If sequencing facilities for a specific syndrome are available, sequencing of 
specific genes should be considered for individuals with clinical features 
strongly associated with that syndrome. As long as these facilities are not 
available in Indonesia, it is possible to send samples to diagnostic centres 
abroad in order to molecularly confirm the specific syndrome. 
e. If sophisticated genetic analyses such as whole exome sequencing will be 
available in the future, this analysis should be considered for individuals with 
negative results after extensive conventional genetic analyses (Baker et al., 
2012; Dixon-Salazar et al., 2012; de Ligt et al., 2012). In the future, such state-
of-the-art genetic analyses may replace those conventional tests. 
f. If facilities for metabolic investigations will be available in the future, these 
analyses can be considered for ID individuals. Some of metabolic disorders, 
although it has a low yield, are known to be treatable if diagnosed early in life 
(van Karnebeek, 2012); take for example, phenylketonuria and congenital 
hypothyroidism. Therefore, the screening for these disorders should be 
performed during neonatal period. The neonatal screening for such disorders 
should receive attention from the government of Republic Indonesia and 
should become one of the public health priorities in Indonesia. 
g. Neuroradiologic/brain imaging facilities are available but at a limited scale and 
expensive. Neurological imaging studies have a high yield for brain 
abnormalities, but low for establishing aetiological diagnoses (van Karnebeek, 
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2005). Therefore, such studies should not be performed in each individual, but 
only if specific symptoms are present such as abnormal head circumference, 
focal neurological findings and symptoms at clinical history taking or physical 
examination that indicate a high chance for a brain anomaly.  
Points a and b are highly recommended in a routine setting. Points c, d, e, f and g are 
recommended for future studies aiming at detecting the aetiological diagnosis in 
individuals with ID. It should be taken into account that points c, d, e, f and g can also 
be considered for routine setting in the future, when these facilities are available and 
affordable in Indonesia.  
6.3. 3. Flowchart of diagnostic protocol 
Following is the proposed flowchart of the diagnostic protocol for Indonesian ID 
individuals (see Table 6.1). Although this flowchart is designed to be applied nation 
wide, it should be considered that at this moment in many areas mainly outside of Java 
Island are of minimum facilities thereby laboratory/additional investigations cannot be 
performed. This can be anticipated with referring the patient to the nearest facility. In 
addition, some additional investigations, however, are not yet available in Indonesia. 
Collaboration with other centres abroad is needed to overcome this problem.  
Table 6.1. Proposed flowchart of the diagnostic protocol for Indonesian ID 
individuals 
No. Step Remarks 
1. History taking  
 Family history  
             Three generation pedigree Including: stillbirths, miscarriages; 
history of ID, psychiatric disorders 
and developmental delay/learning 
difficulty; consanguinity, increased 
age and education level of parents 
 Medical history / developmental history  
             Prenatal Including: possible teratogenic 
exposures, prenatal infections, 
maternal diabetes, amount of 
amniotic fluid and movement of the 
foetus 
             Perinatal Including: delivery process, birth 
measurements, feeding, sleeping 
pattern, hypotonia 
             Postnatal Including: growth parameters, 
developmental milestones,  history 
of trauma/injury, illness and 
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medication, surgery, seizures, 
regression. 
2. Clinical examination  
             Physical measurements Including: length, weight, OFC, 
OCD, ICD, IPD, THL, PL, testicular 
volume (in male). On special 
indications: arm span, sitting height. 
             General aspect and   
            dysmorphological assessment 
Including: general habitus, 
craniofacial, thorax, abdomen, 
genitalia, upper and lower 
extremities 
             Other examination Including: general neurological 
investigation, skin and appendages, 
hearing and vision. 
             Behaviour Including: general impression of the 
personality, peculiar manners: 
posture, movement, walking, mimic 
and stereotypes. 
             Clinical photographs  Including: standard face, side face, 
general body profile, side body 
profile, hands and feet; other 
structures on indication. 
3. IQ data If no IQ data available, refer the 
individual to psychologist. Retest if 
IQ data is different from actual 
observation or testing was not done 
recently. 
4. Laboratory/technical investigation  
             Chromosome analysis For each individual: including 
standard GTG banding and other 
banding on indication. 
             FMR-1 PCR analysis For each individual with normal 
chromosome analysis.  
             Submicroscopic     
rearrangements 
For each individual with normal 
chromosome analysis and FMR-1 
PCR analysis and/or suspicion of 
CNV/microdeletion syndrome 
5. Additional investigation on indication  
            Investigation on specific 
monogenic diseases 
Suspicion of other monogenic 
diseases 
            WGS/WES When the conventional genetic 
analyses could not identify the cause 
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of ID and genetic abnormality has 
been strongly suspected.  
             Neuroimaging Neurological problems,  
macrocephaly, microcephaly, cranial 
contour abnormalities, epilepsy, 
focal neurological findings 
            Metabolic Suspicion of metabolic diseases 
 
6.4. Recommendations and future directions 
6.4.1. Recommendations  
Diagnostic evaluation of an ID individual ideally should be performed with a 
minimal burden for the affected individuals, parents and society. In addition, it should 
be simple, cheap and minimally invasive. On the other hand, the evaluation should be 
evidence based and using the newest developments for which it may need 
sophisticated and expensive technology (Baker et al., 2012). Protocols and guidelines 
for diagnostic evaluation should be arranged such as to be both up-to-date and feasible 
(Sullivan et al., 2011). Nevertheless, local setting, availability of diagnostic facilities and 
financial aspects should be taken into account.  Based on the results of this thesis the 
following is recommended for the Indonesian setting: 
1. As an aetiological diagnostic investigation is of utmost 
importance for ID individuals, parents, medical practitioners 
and care-givers, a nation-wide study is recommended for ID 
individuals with at least chromosome analysis and FMR1 
analysis. Therefore, the government of Republic Indonesia 
and  private initiatives should allocate a budget in the health 
insurance for such a study. Furthermore, they should allocate 
budget to develop diagnostic facilities and human resources 
for genetic diseases.  
2. This study proposes a protocol and guidelines for the 
diagnostic investigation of ID individuals. One of the essential 
steps is history taking, which is often very difficult to obtain 
due to factors described elsewhere in the thesis (chapter 
6.1.2). Furthermore, perinatal data is of the utmost 
importance in determining the aetiology of ID. Acquired 
disorders during pregnancy, delivery, or the neonatal period 
are important causes of ID. Further improvement of perinatal 
care and registration of basic data on pregnancy, delivery and 
neonatal period in every newborn are needed. In order to 
avoid unnecessary expensive laboratory investigations in 
individuals with acquired disorders, the availability of such 
information is needed. It is recommended, therefore, that 
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such information be obtained from parents and/or health care 
facilities prior to admission of ID individuals to schools and 
institutions. In addition, schools and institution should keep 
these data on affected individuals. This is eventually to 
reduce costs and to increase the yield of expensive genetic 
analysis.   
3. Medical students, residents and specialists such as 
paediatricians or neurologists should have a proper training in 
the field of genetics, dysmorphology and syndromes in 
general. Furthermore, these clinicians should have access to 
the major dysmorphology textbooks, electronic catalogues 
(e.g. London Dysmorphology Database and Possum) as well 
as online databases (e.g. Phenomizer and ECARUCA).  It 
should be taken into account that routine laboratory analysis 
is less cost effective than targeted diagnostic work-up which 
is preceded by a clinical diagnosis of a specific syndrome. In 
addition, properly trained physicians will be in a far better 
position to explain to parents about the results of cytogenetic 
and molecular analyses.  
4. In effort to provide a better service to ID individuals in the 
context of genetic and acquired disorders, basic need of 
genetics department should be fulfilled. First, properly trained 
physician in genetic, dysmorphology and acquired disorders 
should be available. Second, basic clinic for clinical genetics 
should be present. Finally, basic laboratory for cytogenetic, 
molecular and metabolic disorders should be available. It 
should be considered that, the cost invested in the basic need 
of this department is much lower than the investment in 
sophisticated apparatus such as for DNA microarray and 
WGS/WES. In addition, fulfilling basic need of genetic 
department is more cost effective to be implemented in 
Indonesian setting. Therefore, providing basic need for 
genetics department should be one of Indonesian public 
health priorities. 
5. Common questions of parents of affected individuals are 
related to management and treatment. Since for most genetic 
diseases, there is no cure, priority should be given to the 
treatment of co-morbidities as well as behavioural disorders 
and wherever possible their prevention. In order to maintain 
continuity of care, a complete record of all medical 
interventions, and multidisciplinary management is important. 
It is also recommended that multidisciplinary teams consisting 
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of psychologists, medical specialists/medical practitioners, 
therapists and caregivers should be established in every 
centre of care, such as schools and institutions.  
6. Recurrences are the concern of the affected individual’s 
parents as well as healthy siblings. These concerns must be 
met with genetic counselling. In Indonesia, however, this is an 
uncommon practice. It is recommended that the government 
provides genetic counselling services at least in tertiary health 
care facilities and furthermore recognizes a genetic 
counsellor as an official or registered professional. 
Nowadays, the University of Diponegoro has an official 
training at master level for genetic counsellor. However, it is 
still not officially recognized throughout the country. 
7. Many individuals with ID have complex health issues, which 
are different from those of the general population. Primary 
care for individuals with ID allows early detection and 
intervention of particular health issues faced by them. These 
are important in an effort to improve their quality of life, to 
improve their access to health care, and to prevent suffering, 
morbidity and premature death. Therefore, the establishment 
of primary care providers specialized for ID individuals should 
be considered as a health priority. 
8. Education is one of the most elementary rights of every 
citizen. The law in Indonesia validates that every citizen, 
including people with intellectual disability, has equal rights 
and opportunities to get quality education. However, the 
accessibility of individuals with ID to facilities, which would 
allow them to enjoy equal opportunities to participate in 
education, is still limited. Nowadays, their non-ID counterparts 
take the benefit from free education policy; however, this is 
not the case for ID individuals where only few institutions and 
schools are free of charge (available only in the big cities). 
The Indonesian Government as well as public-private 
partnerships are encouraged to provide better education 
facilities for them. Furthermore, free education for ID 
individuals should be funded from the national budget. 
9. Parent support groups for ID individuals, which now exist only 
in the capital and other big cities, have to be initiated 
nationwide.  
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6.4.2. Future directions 
Research 
1. In the present study, we mainly focused on the genetic 
aetiological diagnostic process. However, financial constraints 
hampered the use of state-of-the-art technologies such as 
array analysis and WES. The fact that we identified only 
about 20% of genetic abnormalities in the population of 
Indonesian ID leaves sufficient room for future studies in our 
cohort using the above mentioned technologies.  
2. In effort to reduce research cost, the availability of reliable 
perinatal data and properly trained doctors in genetics and 
acquired disorders should be considered for future studies. In 
addition, intense screening for perinatal and acquired 
disorders should be performed prior to genetic research.  
3. Normal measurement graphs for the Indonesian population 
are limited to height and weight, and OFC for infants; 
therefore, further studies of other physical measurements 
should be conducted nationwide.  
4. Protocols and guidelines for diagnostic evaluation of 
Indonesian ID individuals which are produced from this thesis 
may need to be evaluated in the future. Studies about the 
validity and yield of the screening recommendations are 
needed. 
5. In the present study, we performed genetic counselling when 
a genetic diagnosis was obtained. Studying the psychological 
effects of these counselling sessions in the family are needed 
in the future. 
 
Care 
 
1. Nowadays, the accurate number of Indonesian ID Individuals is 
not known (chapter 1.1.4). Knowing the accurate number of ID 
individuals is of paramount importance in effort to plan research, 
care and management. A nationwide coordination centre can be 
supportive in registering individuals with ID. This centre may be 
helpful in offering easy access for government, researchers, care 
providers and general practitioners. In addition, it may have a task 
in the education of general practitioners and care providers. This 
centre also may provide further research. 
2. Comprehensive clinics for ID individuals are of major importance 
for evaluating ID individuals. However, there are only 2 such 
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comprehensive clinics in Indonesia, which is very inadequate. In 
addition, facilities and human resources are far from ideal. The 
establishment of new comprehensive clinics for ID should be 
considered, at least one in each major city. When the diagnosis of 
known syndrome has been established, the presence of such 
clinics is vital to monitor its known comorbidities. This eventually 
will help the affected individuals to receive a better management. 
3. Certified clinical geneticist training and the establishment of a 
human genetics association in the country should be initiated. 
4. Improvement of perinatal care and registration of basic data on 
pregnancy, delivery and neonatal period in every newborn are 
critically important. Health care facilities at all levels, such as 
health centres, hospitals, maternity and paediatric clinics should 
improve their ability in these fields.  
5. The implementation of medical genetics in the Indonesian public 
health system is still facing some complicated issues. Nowadays, 
establishing an aetiological diagnosis and providing possibilities 
for carrier testing are still not considered to be useful. This is due 
to the lack of awareness of medical personnel and the public at 
large. Therefore, public dissemination and education through 
workshops and seminars about genetics are of paramount 
importance.  
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Summary 
Intellectual disability (ID) has been defined as a significant limitation in both 
intellectual functioning (IQ<70) and concurrent limitations in conceptual, social and 
practical adaptive skills, manifesting before the age of 18. The aetiology of ID is 
complex and heterogeneous and includes genetic, non-genetic (environmental) and 
multifactorial causes. The details about known genetic aetiologies associated with ID 
are discussed in chapter 1. 
Indonesia ranks fourth on the list of countries with the largest population in the 
world, after China, India, and the United States, indicating that also the ID population 
must be large. However, only a partial genetic diagnostic work-up of the ID population 
in Indonesia has been performed. This study aimed at recording an aetiological 
diagnosis of ID as well as trying to determine the prevalence of cytogenetic and some 
molecular diagnoses, performing phenotype-genotype correlation studies, and defining 
a diagnostic protocol for ID which is applicable in the Indonesian context. 
In chapter 2 we determined the frequency of cytogenetic abnormalities in a 
cohort of Indonesian individuals with ID using conventional cytogenetic analysis 
confirmed by some stand-alone molecular tests. Chromosomal abnormalities were 
found in 87 (16.5%) out of the 527 intellectually disabled individuals, with trisomy 21 
being the major chromosomal abnormality, occurring in 74 cases (14%). The detection 
rate of our study is in the range of the latest meta-analysis study conducted in ID 
individuals. 
In chapter 3 we determined the frequency of Fragile X syndrome (FXS) in 
males and females, and documented their relatives with a similar disorder. Cytogenetic 
analyses revealed that five individuals (four males and one female) out of 87 had FXS. 
Since FXS cannot always be identified by cytogenetic analysis, a follow up study using 
molecular analyses was conducted in the 440 samples (279 males and 161 females) 
without chromosomal abnormalities. This resulted in the identification of four additional 
cases (three females and one male). In the Indonesian ID population, the prevalence of 
FXS is therefore, 9/527 (1.7%), while the prevalence of FXS in males and females is 
1.5% (5/329) and 2% (4/198), respectively. The detection rate of FXS in our study is 
comparable with the latest meta-analysis study. 
In chapter 4 we determined the frequency of subtelomeric deletions and 
duplications using MLPA in a cohort of Indonesian individuals with ID who had a normal 
karyotype and who were FXS negative. The frequency of subtelomeric rearrangements 
in this study was 3.7% (16/436). In addition, in one of the positive individuals, we 
identified a monosomy 9pter and trisomy 9q34.11qter, which appeared also to be 
present in her sister. The familial nature of this rearrangement is explained by a 
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maternal pericentric inversion. Our results on subtelomeric rearrangements are 
comparable with the latest meta-analysis study. 
In chapter 5 we investigated a subset of ID individuals suspected of having a 
specific syndrome. A case with Mowat-Wilson syndrome and the results of sequencing 
of several genes involved in autosomal recessive primary microcephaly are described. 
  In chapter 6, the implication of this work including the establishment of a 
diagnostic protocol for the Indonesian setting is described. In addition, a general 
discussion and future directions towards a better genetic diagnostic workup in 
Indonesia having limited laboratory facilities are also provided.  
In summary, this thesis provides evidence that clinical evaluation and relevant 
genetic investigations can achieve diagnoses in a significant proportion of cases. In 
spite of the fact that the diagnostic possibilities in developed countries are far more 
advanced than the tests discussed in this thesis, it is evident that our studies are a 
fundamental step for aetiological diagnostic evaluation of ID individuals in Indonesia. As 
copy number variations, single nucleotide variations, and metabolic disorders are 
causes of ID that were not studied in our cohort, these causes call for further 
investigation in future studies. 
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Samenvatting 
Intellectual disability (ID), in het Nederlands verstandelijke beperking, wordt 
gedefinieerd als een significante beperking in zowel intellectueel functioneren (IQ <70) 
als beperkingen in conceptuele, sociale en praktische adaptieve vaardigheden, die vóór 
het 18de
Indonesië heeft na China, India en de Verenigde Staten, de grootste bevolking 
ter wereld, wat suggereert dat ook de ID populatie groot moet zijn. Echter, de 
genetische studies die zijn uitgevoerd bij de ID bevolking van Indonesië zijn zeer 
beperkt. Deze studie is gericht op het stellen van etiologische diagnoses voor ID 
waarbij de prevalentie van cytogenetische en een aantal moleculaire diagnoses in kaart 
wordt gebracht, op het uitvoeren van fenotype-genotype correlatie studies en op het 
definiëren van een diagnostisch protocol voor ID in de Indonesische context. 
 levensjaar tot uiting komen. De etiologie van ID is complex en omvat 
genetische en niet-genetische factoren (omgeving) of een combinatie hiervan. De 
details over de bekende genetische oorzaken geassocieerd met ID worden besproken 
in hoofdstuk 1. 
In hoofdstuk 2 hebben we de frequentie van cytogenetische afwijkingen in 
een cohort van Indonesische individuen met ID bepaald met behulp van conventionele 
cytogenetische analyses, die bevestigd zijn met een onafhankelijke moleculaire test. Bij 
87 van de 527 verstandelijk beperkte individuen (16,5%) werd een chromosomale 
afwijking gevonden, waarbij trisomie 21 de meest voorkomende chromosoom afwijking 
was, gevonden bij 74 individuen (14%). De detectie ratio in onze studie ligt binnen de 
grenzen van de meest recente meta-analyse studies uitgevoerd bij ID individuen. 
In hoofdstuk 3 hebben we de frequentie van het Fragiele X syndroom (FXS) 
bepaald bij mannen en vrouwen, en zijn hun aangedane familieleden gedocumenteerd.  
Vijf personen (vier mannen en een vrouw) van de 87 met een cytogenetische afwijking 
hadden FXS. Omdat FXS niet altijd met cytogenetische testen kan worden aangetoond, 
werd een vervolgstudie met moleculaire analyses uitgevoerd bij de 440 individuen (279 
mannen en 161 vrouwen) zonder chromosomale afwijking. Dit resulteerde in de 
identificatie van vier extra gevallen (één man en drie vrouwen) met FXS. In de 
Indonesische ID populatie is de prevalentie van FXS dus 9/527 (1,7%), waarbij de 
prevalentie bij mannen en vrouwen respectievelijk 1,5% (5/329) en 2% (4/198) is.  De 
detectie ratio van FXS in onze studie is vergelijkbaar met die in recente meta-analyse 
studies. 
In hoofdstuk 4 hebben we met MLPA de frequentie van subtelomere deleties 
en duplicaties bepaald in een cohort van Indonesische individuen met ID, die een 
normaal karyotype hadden en FXS negatief waren. De frequentie van subtelomere 
afwijkingen in deze studie was 3,7% (16/436). In een van de positieve individuen 
hebben we een monosomie 9pter en een trisomie 9q34.11qter geïdentificeerd, die ook 
aanwezig bleek te zijn bij haar zus. De aanwezigheid van deze chromosomale afwijking 
bij twee kinderen kon verklaard worden door een pericentrische inversie bij de moeder. 
Onze resultaten m.b.t. subtelomere afwijkingen zijn vergelijkbaar met de meest recente 
meta-analyse studie. 
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In hoofdstuk 5 hebben we een gedeelte van de ID individuen, die er van 
verdacht werden een specifiek syndroom te hebben, onderzocht. Een casus met 
Mowat-Wilson syndroom en de resultaten van de analyse van genen betrokken bij 
microcefalie worden beschreven.    
In hoofdstuk 6 worden de implicaties van het onderzoek besproken, inclusief 
het opstellen van een diagnostisch protocol voor Indonesisch gebruik. Daarnaast wordt 
een algemene discussie en toekomst perspectief op een betere genetische diagnostiek 
in Indonesië gegeven.   
Samengevat, levert dit proefschrift het bewijs dat een klinische evaluatie en 
relevant genetisch onderzoek kan leiden tot een diagnose in een significant deel van de 
gevallen. Ondanks het feit dat de diagnostische mogelijkheden in ontwikkelde landen 
veel groter zijn dan de testen die in dit proefschrift worden besproken, is het duidelijk 
dat onze studies een belangrijke bijdrage leveren aan de ontwikkeling van een 
etiologische diagnostische evaluatie van ID individuen in Indonesië. Omdat geen 
onderzoek is gedaan naar veranderingen in kopie nummer, naar veranderingen in de 
sequentie, en naar metabole aandoeningen als oorzaak van ID, ligt er nog een weg 
open voor toekomstig onderzoek. 
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Intisari 
Disabilitas intelektual (DI) didefinisikan sebagai keterbatasan fungsi intelektual 
dibawah rata-rata (IQ<70) yang disertai dengan keterbatasan dalam melakukan 
aktivitas sehari-hari, berfikir secara konseptual dan kritis, serta dalam menyesuaikan 
diri dengan masalah dan kondisi situasi sosial. Keterbatasan-keterbatasan ini terjadi 
sebelum usia 18 tahun. DI mempunyai etiologi yang kompleks dan heterogen, 
termasuk didalamnya penyebab genetik, non-genetik (lingkungan) dan multifaktorial. 
Etiologi genetik yang terkait dengan DI dibahas dalam bab 1. 
Indonesia menempati urutan keempat negara-negara dengan populasi 
terbesar di dunia, setelah China, India, dan Amerika Serikat, menandakan jumlah 
penduduk dengan DI juga banyak. Namun begitu, diagnosis genetik yang telah 
dilakukan selama ini pada populasi DI di Indonesia hanya sedikit. Penelitian ini 
bertujuan untuk mendata diagnosis etiologi dari DI, menentukan prevalensi kelainan 
kromosom dan beberapa kelainan molekuler, melakukan studi korelasi fenotip genotip, 
dan menegakkan protokol diagnostik untuk DI yang sesuai dengan kondisi di 
Indonesia. 
Dalam bab 2 dibahas tentang frekuensi kelainan kromosom pada individu 
dengan DI di Indonesia menggunakan analisis kromosom konvensional yang 
dikonfirmasi dengan beberapa tes molekuler independen. Kelainan kromosom 
ditemukan pada 87 (16,5%) dari 527 individu dengan DI dimana trisomi 21 menjadi 
kelainan kromosom utama yang terjadi pada 74 kasus (14%). Penelitian ini sesuai 
dengan studi meta-analisis terbaru yang dilakukan pada individu dengan DI yang telah 
dilakukan sebelumnya. 
Dalam bab 3 dikemukakan tentang frekuensi Fragile X syndrome (FXS) pada 
laki-laki dan perempuan yang selanjutnya dilakukan pendataan pada kerabat yang 
mempunyai gangguan yang sama. Analisis kromosom mengungkapkan bahwa lima 
orang (empat laki-laki dan satu perempuan) dari 87 memiliki FXS. Karena FXS tidak 
selalu dapat diidentifikasi dengan analisis kromosom, maka penelitian lanjutan 
menggunakan analisis molekuler dilakukan pada 440 sampel (279 laki-laki dan 161 
perempuan) yang tidak mempunyai kelainan kromosom. Studi lanjutan ini 
mengidentifikasi empat kasus tambahan (tiga perempuan dan satu laki-laki), sehingga 
pada populasi DI di Indonesia prevalensi FXS adalah 9/527 (1,7%), dimana prevalensi 
FXS pada masing-masing laki-laki dan perempuan adalah 1,5% (5/329) dan 2% 
(4/198). Tingkat deteksi FXS dalam penelitian ini sebanding dengan studi meta-analisis 
terbaru. 
Dalam bab 4 frekuensi kelainan delesi dan duplikasi subtelomerik telah 
diidentifikasi menggunakan metode Multiplex Ligation-dependent Probe Amplification 
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pada individu dengan DI di Indonesia yang memiliki kariotipe normal dan FXS negatif. 
Frekuensi kelainan tersebut dalam penelitian ini adalah 3,7% (16/436). Selain itu, pada 
salah satu individu dengan kelainan ini, kami mengidentifikasi kelainan 9pter monosomi 
dan trisomi 9q34.11qter yang terjadi juga pada adik perempuannya. Kelainan ini terjadi 
akibat adanya inversi perisentrik pada ibunya. Hasil studi tentang delesi dan duplikasi 
subtelomerik sebanding dengan studi meta-analisis terbaru. 
Dalam bab 5 dibahas tentang penelitian pada sebagian dari individu dengan 
DI yang diduga memiliki sindrom tertentu. Pada bab tersebut ditampilkan sebuah kasus 
Mowat-Wilson syndrome dan hasil penelitian menggunakan metode sekuensing pada 
gen-gen yang terlibat dalam autosomal resesif microcephaly primer. 
Dalam bab 6, dibahas secara umum implikasi yang ditimbulkan dari penelitian 
ini termasuk didalamnya dikemukakan penegakan protokol diagnostik yang dapat 
digunakan di Indonesia. Selain itu disampaikan saran-saran demi terciptanya 
pemeriksaan diagnostik genetik yang lebih baik di Indonesia dengan adanya 
keterbatasan fasilitas laboratorium. 
Sebagai intisari, tesis ini memberikan bukti bahwa evaluasi klinis dan 
pemeriksaan genetik yang relevan dapat menegakkan diagnosis yang signifikan pada 
individu dengan DI. Terlepas dari kenyataan bahwa diagnostik genetik di negara maju 
jauh lebih berkembang, namun demikian hasil penelitian ini menyajikan langkah 
mendasar untuk evaluasi etiologi diagnostik pada individu dengan DI di Indonesia. 
Beberapa penyebab DI tidak semuanya dapat diselidiki dalam penelitian ini antara lain 
copy number variations, single nucleotide variations dan gangguan metabolisme. Oleh 
karena itu, penelitian ini perlu dilanjutkan di masa datang. 
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Appendix (Color Figures) 
Chapter 4.2, figure 1 
 
Figure 1. Conventional cytogenetic analysis, FISH analysis and the ideogram of 
the aberration in the patient (left) and her mother (right). 
 
 
Chromosome 9 of the patient showed a duplication of 9q material attached to the p-arm of the 
chromosome (left). FISH results with chromosome 9p telomere-specific probe (green) and chromosome 
9q telomere-specific probe (red); Note the two signals of 9q on the patient's aberrant chromosome 9. 
 
 
Chapter 4.2, figure 2 
Figure 2. 250k SNP array result 
 
A 9pter loss of 460 kb (containing 55 SNPs, 4 genes) and a 8.9 Mb gain of the 9q34.11q34.3 region 
(containing 394 SNPs, 162 genes) were observed. 
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Chapter 4.2, figure 3 
Figure 3. Critical regions associated with duplication 9qter. 
 
 
This schematic illustration is based on hg18. All molecularly well characterized 9qter duplications are 
depicted by arrows. Region 1 has been associated with ID, strabismus, hypotonia, micrognathia, 
microstomia, arachnodactyly and sandal gap. The second critical region (Region 2) is associated with 
facial asymmetry and abnormal behaviour. 
Chapter 5.1, figure 2 
Figure 2: Electropherogram of molecular analysis in the patient sample. 
 
The upper panel shows the heterozygous c.1965C>G (p.Tyr652X) mutation and the lower panel shows 
the wild type (control). The “S” on the electropherogram represents the C/G heterozygote.
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